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by 
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Genetic sequencing has been recognized as an effective approach to accurately address 
biological problems, such as clinical detection of disease, mutation discovery, and targeting 
specific biomarkers associated with complex diseases. Compared with conventional Sanger 
sequencing, next-generation sequencing costs much less due to massively parallel high-
throughput sequencing. However, due to large numbers of short read sequences, the accuracy of 
high-throughput sequencing data remains a challenge in that the data obtained from next-
generation sequencing often has higher error rates, which may impact downstream genomic 
analysis. Even if the downstream genomic analysis performs well, the quality of the result will 
still be impacted by the quality of the data. Before proceeding to downstream analysis, data 
quality assessment is necessary. Error rate estimation studies have been able to describe the 
quality of sequencing reads obtained from a sample. However, these studies may have 
limitations when sequencing a new genome or under a linearity assumption that the number of 
sequences containing errors increases linearly with the number of error-free read counts, which 
may not be available for all types of sequencing data. Therefore, it is necessary to estimate 
sequencing error rates in a more reliable way. In this dissertation, we proposed an empirical error 
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rate estimation approach that employs nonlinear statistical models of cubic smoothing splines 
and robust smoothing splines to analyze the association between the number of shadow counts 
and the number of error-free read counts. Traditional approaches to simulation when analyzing 
sequencing data may not reflect the real structure of the sequencing data. We also proposed a 
frequency-based simulation approach that mimics the real sequencing count framework and has 
more computational efficiency. Based on all the simulation scenarios tested, our proposed 
empirical error rate estimation approach provided more accurate estimations than the shadow 
regression approach. We also redefined the per-read error rate so that it is more flexible and 
provides more information according to the sequencing reads. The proposed empirical error rate 
estimation approach was applied to assess the sequencing error rates of bacteriophage PhiX 
DNA samples, a MicroArray Quality Control project, a mutation screening study, the 
Encyclopedia of DNA Elements project. The proposed empirical error rate estimation approach 
is free from the limitation of a linearity assumption between the number of shadow counts and 
the number of error-free read counts and demonstrates more accurate error rate estimations for 
next-generation short read sequencing data.  
The errors of next-generation sequencing data discussed in the literature concern sequences with 
up to two bases that are different from error-free reads by substitution. In this thesis, we also 
extended the study of error rate estimations to different shadow scenarios, including varying the 
substitution shadows to be sequences in which only one base is different, only two bases are 
different, and up to two bases are different form error-free sequencing reads, and extending the 
investigation to deletion and insertion error rates. The deletion and insertion error rates are 
calculated differently from multiple approaches.  For the extended investigation, both simulation 
studies and real data analyses were performed using empirical error rate estimation approaches 
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and shadow regression approaches. Under the simulation scenarios tested, the empirical error 
rate proved to be more accurate and resulted in less biased estimation for the deletion and 
insertion analysis.  
  
In this dissertation, we also studied the human microbiome, which has been associated with 
complex diseases, for example, cardiovascular disease, diabetes, obesity, and specific cancers. 
To our knowledge, the existing literature has rarely discussed how to process raw human 
microbiome data and convert it into the format of downstream operational taxonomic units. We 
reviewed multiple statistical methods for processing, summarizing and analyzing microbiome 
data, and also provided detailed programming scripts about how to process human microbiome 
data into a downstream analysis format and assess alpha diversities, beta diversities, and the 
association between sample diversities and the outcome of interest. For illustration, the statistical 
approaches were also applied to analyze the foregut microbiome in esophageal adenocarcinoma.  
For future directions of research, we provided a potentially effective strategy for analyzing 
longitudinal human microbiome data associated with complex diseases by using a Bayesian 
network approach. The Bayesian graphical model approach accounts for interaction with the 
microbiome and captures the common structure of change within the microbiome, which 
provides insights to predict the change in the composition of the microbiome over time and find 
specific microbiome taxa that may be associated with complex diseases.  
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Chapter 1 
Introduction 
 
 
Biomedical research has identified associations between genetic variants and complex human 
diseases. Studies on genetic sequences have provided invaluable insights into complex diseases, 
suggested novel therapeutic strategies, and contributed to effective personalized treatment 
regimens and disease prevention strategies (1, 2). Downstream genomic sequencing analyses 
have been conducted to identify sequences associated with complex diseases using multiple 
sequencing methods. However, it remains a challenge to accurately assess the quality of the 
sequencing data each time a sample is obtained. 
The percentage of reads mapped has been widely used as a quality indicator; however, that does 
not directly address the fundamental question of how much error is present in the samples to be 
studied in downstream genomic analyses (3, 4). Estimating the error rate typically requires using 
a reference genome, which may not be appropriate when sequencing a new genome when such a 
reference genome has not been established.   
In this thesis, we developed statistical models to estimate sequencing error rates, including those 
of substitution, deletion, and insertion in next-generation sequencing data. We also studied and 
reviewed the statistical approaches used to analyze human microbiome data, and provided a 
future direction for analyzing longitudinal human microbiome data. The study on the human 
microbiome may provide novel strategies about effective treatment and prevention of complex 
diseases.   
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In Chapter 1, we introduce multiple sequencing approaches, including Sanger sequencing, next-
generation sequencing, DNA sequencing, RNA sequencing, and 16S rRNA sequencing of the 
human microbiome.  
 
1.1 Sanger Sequencing 
Automated Sanger sequencing represents the first generation of DNA sequencing (5), and has 
been widely used in a diverse range of areas to solve various biological problems and identify 
clinically significant DNA variants associated with disease (6). For example, Sanger sequencing 
has been used to identify an appropriate treatment strategy that inhibits epidermal growth factor 
receptor tyrosine kinase for specific patients with non–small-cell lung cancer (6, 7). Sanger 
sequencing has been used so widely to evaluate non-syndromic hearing loss that most genetic 
testing strategies for this disorder depend on the gene-specific Sanger sequencing technique (8).  
Developed by Sanger and colleagues (9), the original sequencing technology used a chain-
termination sequencing approach to determine nucleotide sequences in DNA. Novel technologic 
developments have been applied to improve Sanger sequencing, resulting in the modern form of 
Sanger sequencing, which detects fluorescently labeled nucleotide sequences by applying 
automated sequencing instruments (6). In Sanger sequencing, a DNA sample is sheared into 
fragments, subcloned into different vectors, and then amplified in bacterial or yeast hosts (10). 
The amplified DNA is then isolated and sequenced with the Sanger chain termination approach.  
Sanger sequencing has a low error rate and was long considered to be the “gold standard” for 
sequencing genetic mutations (11, 12). Sanger sequencing can achieve up to about 1,000 bp, with 
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per-base “raw” accuracies as high as 99.999%, which makes it the most accurate sequencing 
approach currently available (5). Sanger sequencing can read DNA fragments that are 
approximately 500 bp to 1kb in length. Performing traditional Sanger sequencing requires 
moderate expertise; whereas sequencing approaches such as next-generation sequencing require 
a high level of expertise (6). 
Despite the advantage of accuracy and strong availability in Sanger sequencing, there are 
technical limitations in this first-generation sequencing technique. One major limitation involves 
the limited throughput of the DNA sequence that can be read with each sequencing reaction (13). 
Traditional Sanger sequencing is generally restricted to one gene at a time; hence it does not 
easily sequence hundreds of genes in a sample. In addition, traditional Sanger sequencing cannot 
detect deletions, translocations, or gene copy number alterations. (6) Sanger sequencing requires 
electrophoretic separation of DNA fragments for DNA sequence reading, which leads to the 
primary bottleneck for throughput data in this traditional sequencing approach (13). The process 
of Sanger sequencing is lengthy and requires labor-intensive cloning-based amplification that 
also limits its application for high-throughput genome sequencing (10). Another limitation is the 
high cost of traditional Sanger sequencing. With a throughput of Sanger sequencing of 
approximately 115 kb per day (1,000 bp), the current cost to sequence the entire human genome 
using Sanger sequencing is estimated to be up to 30 million U.S. dollars. In addition, using one 
single machine, this task will take approximately 60 years. (13) 
These limitations of Sanger sequencing restrict its use to mainly the generation of reference 
genome sequences of many species, including those of humans.  (10)  
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1.2 Next-Generation Sequencing 
New sequencing approaches have been emerging that overcome the limitations of Sanger 
sequencing. Next-generation sequencing technology has played an essential role in biological 
research. Next-generation sequencing offers radically fast sequencing capability and produces 
large amounts of DNA, which has significantly driven down the cost of genetic sequencing (13). 
For example, one typical next-generation sequencing procedure can sequence millions of short 
reads at the same time and provide high-throughput of parallel DNA sequences in a single 
reaction.  
In general, next-generation sequencing uses double-stranded DNA as the initial input material, 
although the technology can accommodate multiple types of starting materials. Even though the 
source of starting material may vary, the data are then converted into a sequencing library in a 
process that uses common fragmentation steps, size selection, and adapter ligation (13). As the 
sequencing material comes into the fragmentation and size selection stage, DNA templates are 
broken into smaller fragments for further DNA-pair synthesizing, and adapter ligations are then 
added  with synthetic DNA to the ends of the library fragments that serve as primers for 
downstream amplification and sequencing reactions (13). In the next-generation technique, the 
sequencing library is either sequenced directly or is amplified and then is sequenced (13). DNA 
sequencing represents a single format, but projects a wide variety of biological phenomena 
through the analysis of high-throughput sequencing data (5, 13). 
Compared to other sequencing techniques, next-generation sequencing has significantly 
decreased the per-base sequencing cost and increased the sequencing volumes, which always 
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leads to high-throughput genome-wide sequencing data. The next-generation sequencing 
approach has a number of appealing features, including the high-throughput capacity of parallel 
sequencing and the ability to simultaneously detect multiple genetic events, including deletions, 
insertions, copy number alterations, translocations, and exome-wide base substitutions 
(especially known “hot-spot mutations”) in genes associated with disease susceptibility (6). 
Moreover, compared with traditional Sanger sequencing, next-generation sequencing is not 
restricted to sequencing a single gene at a time and can generate millions of sequencing reads 
simultaneously using a surface area of a reasonable size (5, 6). With the advent of high-
throughput next-generation sequencing, genomic investigations have expanded to include a more 
diverse range of genomic alteration phenomena, which has opened entirely new areas of 
biological inquiry, such as single-nucleotide polymorphisms (14), epigenetic events (15), copy 
number variants (16), differential expression (17), alternative splicing, the characterization of 
ecological diversity, and the identification of unknown etiologic agents (6, 18-20). In addition, 
next-generation sequencing platforms have enabled researchers to directly sample the nuclear 
genomes obtained from ancient remains, including those of a cave bear (21), mammoth (22), and 
Neanderthal(18, 23, 24). Next-generation sequencing has widened the scope of metagenomic 
analysis to environmentally derived samples (18).  
Despite the advantages of next-generation sequencing, the increased capacity of high-throughput 
parallel sequencing comes at the cost of read length and sequencing accuracy (13). The most 
prominent shortcomings in next-generation sequencing are the short sequencing read lengths and 
raw accuracy, which has affected how the reads are utilized in bioinformatic analyses and 
downstream analyses (5, 18). In addition, researchers face the computational challenge of 
mapping the sequenced reads against a reference genome to independently verify the alignment 
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of the reads of interest. Moreover, for comprehensive resequencing of short reads, a much higher 
read coverage or sampling depth is required to cover the reference sequence at adequate depth 
and ensure a low gap size in a valid phenotype-genotype association study using the next-
generation technique (18). There is a great need for new statistical approaches to use in the 
generation and analysis of next-generation sequencing since traditional methods have 
shortcomings when measuring the quality of sequencing data. The commonly used per-base 
quality score, which counts the probability of a called base in the read being the true sequence 
base, is quite raw and inaccurate. These misaligned reads and inaccurate quality scores, which 
propagate into genotyping and single-nucleotide polymorphism (SNP) discovery, have become 
general and acute problems in many centers that use rapidly evolving experimental processing 
pipelines, including the 1000 Genomes Project. Even if well-mapped and calibrated reads are 
given, caution should be taken when statistical modeling is used to resolve the case of simple 
SNPs, not to mention the more complicated variations such as multi-nucleotide substitutions, 
insertions, deletions, inversions, and copy number variation. (25) 
Next-generation platforms are affecting a complete paradigm shift, including in the organization 
of large-scale data production, downstream bioinformatics, information technology, 
computational data storage, and support of laboratory information management infrastructure 
(18). Existing data analysis pipelines that use next-generation data and the accompanying 
algorithms must be adjusted to accommodate short read sequencing data. For example, new 
algorithms and data visualization interfaces are being devised and modified to satisfy the 
demands in next-generation sequencing (18).  
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1.3 RNA Sequencing 
Another application of next-generation sequencing is RNA sequencing, which uses the next-
generation sequencing approach to sequence, map, and quantify a population of transcripts (10, 
20, 26). RNA sequencing transcriptomes can be profiled with deep sequencing technologies (27). 
Deep sequencing technologies for RNA sequencing are invaluable for detecting RNA expression 
levels and identifying changes in RNA structure (28). At the time of sequencing, a general 
procedure is to convert a region of RNA to cDNA fragments with adaptors attached to either one 
or both ends of the read (29). After the initial sequencing, short sequences, ranging from 30 to 
400 bases, can be generated in a high-throughput manner (29).  
RNA sequencing technology provides a precise measurement of the levels of transcripts and 
isoforms (27). The transcriptome refers to the complete transcript set in a cell, and the 
corresponding quantity can be synthesized and then measured in a specific developmental stage 
or condition via RNA sequencing (27). With RNA sequencing, it is feasible to distinguish 
specific genomic locations of transcription boundaries in the fairly high resolution of a single 
base pair as well as the rare variations in transcription regions (29-31). In addition, mRNA 
expression studies that use RNA sequencing have been utilized in microarrays or quantitative 
polymerase chain reactions (18). The identification of epigenetic events by investigating changes 
of RNA expression in RNA sequencing can be used to reveal historical environmental exposures 
and identify associated impacts in disease (28). Another big contribution of RNA sequencing is 
to address the heritability component of both common and rare variants, and measure the 
interactions between the genome and the environment in biological studies (28). RNA 
sequencing technology has provided unprecedented insights into the transcriptional complexities 
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of a variety of organisms, including yeast (32), mice (26), Arabidopsis (33), and humans (19, 
20). RNA sequencing has revolutionized the analysis of eukaryotic transcriptomes and has been 
applied to the study of Saccharomyces cerevisiae, Schizosaccharomyces pombe, Arabidopsis 
thaliana, and mouse and human cells (27, 29, 30, 34-37). Benefits of implementing RNA 
sequencing include a potentially unlimited dynamic range of expression, better sensitivity in 
genetic sequencing, greater capacity to discriminate regions of high sequence identity, and the 
ability to profile transcription without prior assumptions on which genomic regions are expressed 
(38). The analysis of RNA sequencing has generated an unprecedented global view of the 
transcriptome and the corresponding organization and grouping for species and cell types (27). 
Compared to DNA sequencing, RNA sequencing provides a lower background signal and does 
not require an upper limit of quantification that correlates with the number of sequencing reads 
that would be obtained in the sequencing procedure (27).  RNA sequencing also facilitates 
learning the dynamics of the transcriptome across different tissues or conditions without data 
normalization (27, 30, 36). For example, researchers have utilized RNA sequencing to accurately 
monitor gene expression in yeast vegetative growth (34), yeast meiosis (35), mouse embryonic 
stem cell differentiation (30), and to track and measure the differences in gene expression 
between various tissues (27, 36).  
After obtaining sequencing data, the most urgent challenge arises from mapping the RNA 
sequencing data to the reference genome, which is regarded as much harder than mapping the 
data derived from DNA due to the high-throughput sequencing  (38). RNA sequencing brings 
additional challenges of how to efficiently store, retrieve, and process large volumes of 
sequencing data and how to reduce sequencing errors and remove low-quality sequencing reads 
(27). Typically, the larger the set of sequencing genomic data, the more complicated the 
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statistical modeling of the transcriptome. This occurs because sufficient sequencing depth must 
be controlled to achieve adequate coverage of such a large volume of data (27). Improper control 
will result in complicated, error-prone estimations of the transcriptome coverage since it is hard 
to know the usual number and level of different transcript isoforms, and the activity of 
transcription can vary across the genome (27). For example, when dealing with rare RNA 
isoforms, it becomes even harder to use RNA sequencing to target these complicated 
transcriptomes to monitor the changes in gene expression levels across the whole genome (27).  
 
1.4 Human Microbiome 
Another application of next-generation sequencing technology is the sequencing of the human 
microbiome (18). The advantages offered by next-generation sequencing techniques have 
initiated a revolution in our understanding of how the human microbiome affects a human health 
and diseases (18). Recent technologic advances have enabled the deep sequencing and analysis 
of the composition of the microbiome (39). The microbiome refers to the entire set of 
microorganisms living within a given habitat and the corresponding genomes and surrounding 
environmental conditions (40). The metagenome consists of the complex set of genetic 
sequences of the microbiome plus human DNA sequences (41).  
The human microbiome interacts dynamically with our daily environment and is essential to 
human health (42). Studies have suggested that the human microbiome plays a central role in an 
individual’s nutrition, immunity, and protection from various pathogens within the body (41, 43, 
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44). The microbiome functions within a complicated microbial community and processes energy 
and materials for the human body (45, 46). According to the Human Microbiome Project, the 
majority of microbial species in humans have never been isolated or cultured due to our inability 
to reproduce the necessary growth conditions in the lab (47). 
The human body is inhabited by a complicated collection of microbes that includes bacteria, 
fungi, viruses and eukaryotes that live symbiotically within several highly specific environments 
that may vary according to the individual’s health status (18, 39, 42). On average, each human 
hosts a microbiome that consists of 10-100 trillion symbiotic microbial cells, which are almost 
10 times the total number of human somatic and germ cells in the body (42, 45, 46). The 
composition of the microbiome varies according to the individual’s genotype, health, diet, 
lifestyle, social interactions, early use of antibiotic therapy, and exposure to environmental 
chemicals (45, 48). The variation of bacterial species within the microbiome is significantly 
different between individuals, and the corresponding composition in the microbiome impacts its 
habitat (41, 44). The composition and diversity of the microbiome may be further  impacted by 
the mode of birth delivery, and hospitalizations (41). For example, dietary habits may impact the 
phylogenetic diversity and function of the human microbiome in disease risk and penetrance 
(41).  
In addition, the composition of the microbiome undergoes dynamic change in the human body 
over time. For example, the intestinal microbiome changes dramatically in composition 
throughout infancy and childhood (41). A study showed that the composition of the gut 
microbiome is significantly different between adolescents, children, and adults, which implies 
that the composition of the human microbiome evolves during the periods of childhood and 
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adolescence (41). Therefore, the study on longitudinal data in humans may provide essential 
insights and further understanding of the fundamental interactive structure of the human 
microbiome and its association with complex diseases.  
The understanding and recognition of the importance of the human microbiome has not been 
fully accomplished due to the complicated and dynamic nature of the microbiome and the limited 
sequencing analysis related to the microbiome (39). Studies of the human microbiome may 
provide diagnostic solutions for certain diseases and play a role in standard clinical practice in 
the future (39).  
 
1.4.1 16S ribosomal RNA Sequencing 
One major application in the analysis of the human microbiome using next-generation 
sequencing methods refers to 16S ribosomal RNA (rRNA) sequencing, which identifies and 
compares bacteria within a given sample (49)[49]. The 16S rRNAs are the genes encoding from 
a ribosomal RNA molecule, which are conserved in both bacteria and archaea (40). The 16S 
rRNA sequencing procedure allows for the identification of species from a complicated mixture 
of the microbiomic community (40). The terms “16S rRNA gene” and “16S rDNA gene” have 
been used interchangeably. The current Application Security Manager (ASM) policy uses the 
term “16S rRNA” (50). The 16S rRNA sequences are often between 500 bp and 1550 bp in 
length(50). Universal primers are utilized that are complementary to conserved regions. The 
sequences in the variable region are utilized as comparative taxonomy (50).  
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With the rapid development of sequencing technology, 16S rRNAs have been  widely used as the 
primary tool to investigate taxonomic assignment and phylogenetic trees (51). For instance, 16S 
rRNA has been commonly used for phylogenic study, taxonomic classification, and to infer 
microbiome diversity of clinical or environmental samples (51).  
One prominent advantage that makes 16S rRNA the primary tool in microbiome sequencing is 
that 16S rRNA is universal in bacterial. 16S rRNA is present in at least one copy over all the 
bacterial genome, which makes the comparison and measurement in the same window for all the 
bacteria. Another advantage is the stability in 16S rRNA that the corresponding function in 16S 
rRNA does not vary over time. In addition, the 16S rRNA genes are adequately large for 
informatics purposes, and the conserved regions are available for simple sample identification. 
16S rRNA sequencing provides reliable information on the bacterial family or species (50-52) . 
16S rRNA sequencing provides rapid, robust, reproducible, and accurate identification measures 
for various bacteria, which may lead to clinical improvements, such as the discovery of novel 
pathogens and identifying noncultured bacteria (50). Studies that analyze 16S rRNA gene 
sequencing contribute to further understanding of clinical microbiology and associated infectious 
diseases, enables accurate identification on the level of the microbiome species, and clarifies the 
associated clinical importance (50).   
 Despite the advantages associated with using 16S rRNA sequencing, a downside of the 16S 
rRNA technique may refer to the difficulty in specifying the one-to-one correspondence. As 
there are more distinct taxonomy than the well-known ones that have names or phenotypic 
descriptions, it is challenging to assign names to each taxon in a meaningful way (50). Another 
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downside may refer to the high expertise requirement for technical skills and the high cost of 16S 
rRNA sequencing (50).  
Currently, there are two established approaches for utilizing 16S rRNA to measure and quantify 
the microbiome and assign sequences to different microbiome groups at different taxonomic 
levels. These two established approaches are the phylotypes approach and the operational 
taxonomic units approach (40). The phylotypes approach depends on the comparison with 
reference sequences and assignment into taxonomic bins. The phylotypes approach searches 
public databases, such as the Ribosomal Database Project (53), the SILVA database (54), or the 
Greengenes database (40, 55). The major benefit of using the phylotypes approach is that it 
enables sequencing classification based on the previously characterized and often clinically 
related microbiome (40). A limitation is that this approach lacks a coherent definition of the 
reference sequences for the bacterial species for the whole taxonomic lineage, which makes it 
impossible to consistently define bacterial taxa (40). There are also conflicts in several widely 
used taxonomies regarding taxonomic lineages (40). The second approach to measuring 
microbiome communities refers to operational taxonomic units (OTUs), where 16S rRNA gene 
sequences are clustered into OTUs at a pre-specified similarity threshold (usually the threshold is 
defined to be 97%), which are equivalent to species-level clusters (40). The approach of 
measuring the OTUs overcomes the limitations in the phylotypes approach, which lacks a 
coherent definition for all taxonomic lineages. Initially, the OTUs measuring approach calculates 
the taxonomic unit independently from a reference database. Sequences that can be mapped to 
known bacteria are assigned to the known taxonomy, while sequences that do not match the 
known taxonomy are clustered based on similarity (40). A table about abundance within the 
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microbiome can be generated and used for downstream statistical analysis with species counts or 
compositional structure. 
In the use of 16S rRNA for microbiome studies, a harmonious set of guidelines and measures for 
the interpretation of sequencing data is necessary in order to accurately compare the results 
between different studies (52). Standard 16S rRNA gene sequencing downstream analysis 
includes microbiome alpha diversity, beta diversity, and an association study. The diversity is an 
estimate to characterize and quantify the structure of a microbiome community based on 
measuring information, including the number of species (richness) and relative abundance 
(evenness) (40). The alpha diversity estimates the diversity within a sample, such as the Shannon 
index (56), Simpson index (57), and Chao1 (58) estimators. Furthermore, the beta diversity 
estimates the between-sample habitat diversity, which describes the distance or similarity 
between samples (40). Some widely used beta diversity measures include Bray-Curtis (59), Cao 
dissimilarity index (60), and UniFrac (61).  
As adapting 16S rRNA gene sequencing as a tool in species identification is still a relatively new 
undertaking in most clinical laboratories, the standard measuring approaches will continue to 
evolve over time (52). Despite the accuracy in 16S rRNA, this type of analysis has not been 
widely implemented in large clinical and research laboratories due to technical and cost 
considerations. Thus, further studies in 16S rRNA sequencing may depend on translating 16S 
rRNA sequencing information into convenient biochemical testing schemes and making it 
available in a routine analysis format (50).  
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1.4.2 16s rRNA versus Whole-Genome Shotgun Sequencing 
16S rRNA has been widely used to study species composition in bacterial communities (62). 
However, 16S rRNA sequencing might be biased when unequal amplification occurs in the 
sequencing process and a direct genetic identification is lacking (62, 63).  
An alternative method for studying bacterial composition and diversity is whole-genome shotgun 
sequencing, which utilizes a sequencing technique with random primers to sequence overlapping 
regions in a genome (62, 63). In whole-genome shotgun sequencing, DNA sequences are 
extracted from all cells in a community and subsequently sheared into small fragments that are 
independently sequenced. The small fragments are then aligned to various genomic locations 
(64). Whole-genome shotgun sequencing can be used to sequence the genome over all 
microorganisms in a sample, whereas the domain of 16S rRNA is restricted to bacteria and 
archaea (65).  
The major advantage to whole-genome shotgun sequencing is the capacity to identify taxa more 
accurately at the species level (63). Studies have shown that whole-genome shotgun sequencing 
can detect a more specific taxonomic and functional classification of sequencing reads (65, 66). 
Whole-genome shotgun sequencing also allows for the simultaneous study of archaea, viruses, 
virophages, and eukaryotes (66, 67).  
Despite its benefits, whole-genome sequencing presents several challenges. The shotgun 
metagenomic sequencing is more expensive and usually not deep enough to detect rare species 
within the microbiome (62, 63). In addition, shotgun sequencing requires more extensive data 
analysis and sequencing a genome with high coverage in order to identify and understand the 
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taxa in bacteria (63). Moreover, the relative abundances obtained from shotgun sequencing vary 
significantly depending on the DNA extraction and sequencing protocol (62). When the genome 
database is limited, it may miss taxa due to unassigned sequences in the whole-genome shotgun 
sequencing approach (68). As the metagenomic dataset is relatively complicated and large, it 
may also be difficult to determine from which read the genome was derived (64). 
16S rRNA sequencing has been the most commonly employed approach to study bacterial 
microbiomes (63). Previous studies revealed that 16S rRNA sequencing can profile bacterial 
communities in greater detail than shotgun sequencing. In addition, 16S rRNA sequencing can 
better identify species with low abundance compared with shotgun sequencing (62). Moreover, 
16S rRNA sequencing is cost-effective, and allows data analysis to be performed on established 
pipelines (63). There is a large number of archived datasets available for reference in 16S rRNA 
sequencing (63). Studies have also shown that it may be more appropriate to use 16S rRNA 
sequencing for the analysis of a large number of samples, such as multiple patients and 
longitudinal studies (65).  
 
1.5 Motivation and Rationale of the Thesis  
Next-generation sequencing has been used to address a wide variety of biological investigations, 
for example, quantification of gene expression, microRNA profiling study, genome-wide 
association study of protein–DNA interactions, and polymorphism and mutation discovery (4, 5, 
69-75). Next-generation sequencing applied to the clinical practice of medicine has laid the 
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foundation of personalized genome-based medicine, which is enhancing the accuracy and 
efficiency of disease diagnosis and treatment (13).  
Due to the high capacity of parallel sequencing and much smaller reaction volume in next-
generation sequencing, large-scale research projects have quickly come to depend entirely on 
next-generation sequencing because of the accompanying advantages in cost and sequencing 
capacity, and the practical aspects of implementation (4, 5, 69, 74).  
However, the quantity of large number of short reads and quality of the data in next-generation 
sequencing has posed challenges for biostatistics and bioinformatics in terms of sequencing 
quality scoring (5). The quality and quantity of next-generation sequencing  ultimately 
determines the comprehensiveness and accuracy of the downstream statistical analysis (13). 
Qualitatively, the platforms of next-generation sequencing provide confidence scores for each 
individual base call, and the individual base calling error rates vary based on different 
sequencing platforms (13). According to a study on the chemistry of next-generation reactions, 
the initial portion of each sequencing read is generally more accurate than the latter portion (13). 
Quantitatively, the amount of sequencing data is assessed by the sequencing coverage, which 
refers to the average sequencing time for a base pair in the experiment (13).  
Producing a large number of short reads at the same time leads to difficulty correctly and fully 
assembling the sequencing reads in next-generation sequencing (69). The quality of the 
sequencing data directly impacts the downstream genomic analysis (69, 74, 76). Before 
performing downstream genomic analysis, it is necessary to have quality assessment to ensure 
the sequencing data do not negatively impact the downstream genomic analysis (69, 77). The 
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traditional method that uses a reference to estimate the sequencing error rate depends on a well-
established reference, which has limitations when sequencing new data, such as the microbiome 
or the genome of a new species (69, 78). A shadow regression approach that uses a reference-
free method and is applicable to multiple datasets, including mRNA sequencing data and DNA 
sequencing data, has been proposed. (4, 69) However, the shadow regression approach depends 
on the underlying assumption that the number of sequencing reads with shadows increases 
linearly with the number of error-free sequences, which may not be appropriate for all types of 
sequencing data (69).  
In Chapter 2, an empirical error rate estimation approach is proposed to model the nonlinear 
relationship between the number of sequences with shadows and the number of error-free read 
counts by cubic smoothing spline and robust smoothing spline approaches (69). The per-read 
sequence error rate is redefined, and provides more information according to the sequencing 
reads (69). In addition, a frequency-based simulation approach is developed based on the 
sequencing read counts, which can mimic the real sequencing data structure and reflect the 
nonlinear structure more realistically than Wang et al.’s simulation method (69). The study 
described in Chapter 2 has been published in BMC Bioinformatics (69). 
Chapter 2 focuses on developing an empirical error rate estimation approach for substitution 
error rates, which are the sequencing error rates discussed in the majority of the literature. The 
shadows defined are sequences with up to two bases different from the error-free reads in the 
sample. In Chapter 3, the sequencing error rate estimation is extended to more general scenarios. 
The sequencing error rates are tested by extending the definition of shadows to be different 
numbers of bases in substitution, as well as error rates for deletion and insertion. 
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Chapter 4 describes statistical approaches to study the association between human microbiome 
and outcome of interest. The human microbiome has been associated with complex disorders. 
Advances in sequencing technology have allowed us to generate large amounts of microbiome 
data and enabled the quantification of the composition of the microbiome as high-dimensional 
data. Such a study on the human microbiome will potentially inform the discovery of species in 
the microbiome that are related to human health and disease. This chapter discusses approaches 
for analyzing microbiome data, from the initial steps of processing raw sequencing data to the 
downstream analysis, including assessing community-level diversities and their association with 
outcomes of interest.  
Chapter 5 discusses the extension for the study of human microbiome cross-sectional data to 
longitudinal data, and provides a future direction regarding the analysis of the microbiome 
through a time series of longitudinal data, which can sufficiently reflect the overall performance 
of the composition of the human microbiome over time. A traditional longitudinal analysis of 
microbiome data using a general linear model with a fixed effect or a single summary about 
which indexes change for each sample has limitations, even in well-designed studies. Such 
limitations involve taking the correlation of repeated measures into account and detecting 
important effects on bacterial connections (79, 80). The analytical Bayesian network model for 
longitudinal data not only accounts for the correlation on repeated observations, but also 
performs more accurate estimation than conventional approaches. Chapter 5 provides a future 
direction regarding processing sparse compositional microbiome data and using a Bayesian 
network in a study of longitudinal time-series microbiome data. 
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Chapter 2 
Empirical estimation of substitution sequencing error rates using 
smoothing splines 
 
 
 
 
 
 
 
(Most of the studies in this chapter have been published online in BMC Bioinformatics, 
April 2016: Xuan Zhu, Jian Wang, Bo Peng, Sanjay Shete, “Empirical estimation of 
sequencing error rates using smoothing splines”. According to the journal policy, the 
author retains the right to include the published article in full or in part in a dissertation.) 
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2.1 Background 
 
Complex diseases have been recognized associated with miscellaneous genetic variants. The 
advent of next generation sequencing technology has enabled the studies to investigate a diverse 
range of biological areas and provided unprecedented opportunities and insights to further 
understand multiple disease functions. Next generation sequencing has been used in biological 
investigations, such as identifying disease associated biomarkers, quantification of gene 
expression, microRNA profiling, discovery of transcription factor binding sites, and whole-
genome sequencing (5, 69, 70, 73, 81-83). Next generation sequencing refers to be the massively 
paralleling high-throughput sequencing, which is capable of sequencing millions of short reads at 
the same time (69, 84, 85). Due to large numbers of parallel sequencing and much smaller 
reaction volumes, Next generation sequencing has a number of advantages over conventional 
Sanger sequencing, such as significantly driving down the per base sequencing cost and 
producing high-throughput sequencing (6, 19, 20, 69, 74, 83). Despite the advantages of next 
generation sequencing, large numbers of short-read sequences of this technique makes it difficult 
to correctly and fully assemble the sequences (69, 86-88). In addition, high throughput 
sequencing in next generation sequencing is at a cost of raw accuracy that the error rates in next 
generation sequencing are often higher than those in traditional Sanger sequencing, which has 
become a general and acute problem using next generation sequencing data that negatively 
impacts downstream genomic analysis (4, 25, 74, 83, 89, 90). Therefore, it is essential to assess 
the quality of next generation sequencing data before performing downstream genomic analysis 
(69, 77). Generally, the quality assessment methods include investigating sequence coverage, 
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paired-end and fragment-size distributions, measuring sequence error rates, and quality matrices 
(FastQC) (69, 77, 91, 92).  
Currently, the percentage of reads mapped has been as a quality indicator assessing next 
generation sequencing data; nonetheless, it does not address the fundamental question about how 
much error is present from the sequencing reads in a sample (4). Alternative error rate estimation 
approaches have been developed either using or not using a reference genome. Bullard et al. (93) 
proposed a mismatch sequence counting approach under the assumption that the sequencing 
reads with 0 mismatch had no error and the sequencing reads with 1 or 2 mismatches were errors 
instead of polymorphisms. This mismatch sequence counting approach aligns the reads to a 
reference genome in order to acquire the number of uniquely mapped reads with 0, 1, or 2 
mismatches, and then calculates the per-read error rate as the proportion of sequence reads 
containing errors (83). However, this approach requires a well-established reference, which may 
not be applicable to sequence a new genome (69, 91).  
Another approach using error correction tools according to k-mer (77, 94-100) is capable to 
perform error rate estimation without requiring a reference genome and is less sensitive to errors 
due to polymorphisms (101). Nonetheless, these error correction tools based on k-mer approach 
calculates the frequencies of all distinct sub-strings in the sequence with length k, resulting in 
much computational cost and requiring a large amount of computer memory, which may be 
difficult to apply for large sequencing genomes (69, 102-104). 
Wang et al. (83) developed a shadow regression approach to estimate the error rates for next 
generation sequencing data with the added advantage of not using a reference genome. Based on 
observations, the shadow regression approach estimates the error rates depending on the 
assumption that the number of shadows increases linearly with the number of error-free sequence 
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reads. In shadow regression approach, the per-read error rate referred to the rate of the number of 
sequences containing errors over the total number of sequence reads in a sample. The shadow 
regression approach employs a linear regression model to evaluate the sequencing error rates. 
Nonetheless, in practice, the linearity assumption may not be appropriate for all types of 
sequence data, which might lead to estimation bias when studying sequencing error rates and 
performing downstream genomic analysis (4, 69). 
Consequently, in this study, we proposed the empirical error rate estimation approach to model 
the non-linear relationship between the number of sequence reads containing errors and the 
number of error-free sequences by employing cubic smoothing spline and robust smoothing 
spline approaches. We also redefined the sample per-read error rate which is capable to capture 
the sequence error rate according to the sequence reads and provide more information based on 
read counts. In addition, we developed a frequency-based simulation approach that is capable to 
mimic the real sequence data structure more realistically than the Wang et al.’s simulation 
approach, especially the non-linear relationship between the number of sequences containing 
errors and the number of error-free reads (4, 69). The simulation studies were investigated using 
next generation sequence data from the MicroArray Quality Control (MAQC) project (105), a 
mutation screening study (106), the Encyclopedia of DNA Elements (ENCODE) project (107), 
and bacteriophage PhiX 174RF1 DNA samples (83) and compared the performances between 
shadow regression approach and empirical error rate estimation approach. Under all simulation 
scenarios tested, the proposed empirical error rate approach provided a more accurate error rate 
estimation when the linearity assumption was not valid compared with shadow regression 
approach, and yielded similar error rate estimation when the linearity assumption hold. The real 
data analysis was also performed by applying the proposed empirical error rate estimation and 
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shadow regression approach for MAQC, mutation screening, ENCODE, and PhiX DNA samples 
(69). 
 
2.2 Methods  
 
2.2.1 Shadow Regression Overview 
Wang et al. (83) made the important observation that the number of shadows due to sequencing 
errors increases linearly with the number of reads sequenced, whereas the number of true 
shadows is independent of the number of reads sequenced. In the current study, we employed 
and modified the definitions and notations from the Wang et al. (83) study.  
 
Specifically, given a sequence t in a sample, the total number of reads can be given as 𝑟𝑡 =  𝑛𝑡 +
 𝑒𝑡, where, rt is the total number of reads with sequence t, nt is the number of reads that are error 
free with sequence t, and et is the number of reads that contain sequencing errors with sequence t. 
In practice, one would not know the true error-free sequence reads. Wang et al. first converted a 
sequence file (i.e., fastq format with equal length for all reads) from a sample into a read counts 
file. The number of reads for each sequence was counted over the sample, and then the authors 
ranked all the sequences according to the read counts (see an example of read counts in 
Additional file 2). The top 1,000 reads with the highest frequencies in a sample were selected as 
the error-free sequences and used to calculate nt and et in a different sequence t. The shadows of 
a given sequence t were defined as the reads differing from the error-free reads by up to two 
bases, which was deemed by Wang et al. (83) to be sufficiently similar to the given error-free 
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sequence t to estimate substitution errors. Finally, the top 1,000 reads with the highest 
frequencies in a sample were excluded from the assessment of the shadow counts.   
 
The per-read error rate was defined as the proportion of reads containing sequencing errors over 
all the reads in a given sample (83), or 𝐸𝑅 =  
∑ 𝑒𝑡𝑡
∑ 𝑟𝑡𝑡
=
Δ𝑒𝑡
Δ𝑟𝑡
. Based on the observation that the 
number of shadows due to the sequencing errors increases linearly with the number of reads, 
Wang et al. proposed a linear model as 𝑠𝑡 =  𝛼 +  𝛽𝑛𝑡 +  𝜖, where st is the number of shadows of 
sequence t and ϵ is the independent error that follows approximately Gaussian distribution. 
Robust linear regression was used to estimate the coefficients α and β because shadows can come 
from legitimate error-free reads. In this situation, the per-read error rate can be estimated by the 
slope of the linear model as 𝐸𝑅 =
Δ𝑒𝑡
Δ𝑟𝑡
=
Δ𝑒𝑡
Δ𝑛𝑡+Δ𝑒𝑡
=
𝛽
1+𝛽
, which was denoted as the shadow 
regression error rate (SRER) in the current study. 
 
2.2.2 Empirical Per-Read Error Rate with Smoothing Splines  
 
The error rates assessed by shadow linear regression were based on the assumption of a linear 
relationship between the error-free read counts and shadow counts. However, the real data 
examples in Wang et al.’s paper (e.g., Figure 3) show that for many types of sequencing data the 
relationship between error-free read counts and shadow counts does not follow a linear trend. In 
these situations, shadow regression based on a linear assumption might lead to a biased 
estimation of the sequence error rate. Therefore, in this study, we employed the cubic smoothing 
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spline and robust smoothing spline methods to model the relationship between the error-free read 
counts and the shadow counts; the piecewise curve resulting from these spline methods is 
capable of capturing relationships of widely varying form and tends to avoid erratic behavior 
near the extremes of the data (108). Based on the empirical read-shadow relationship, we 
proposed the error rate estimation as a function of error-free read counts, which we hypothesized 
would be more useful in practice than the shadow regression approach for estimating error rates.  
 
We first used the cubic smoothing spline method (109, 110) to model the shadow counts (st) as a 
function of the error-free read counts (nt). The cubic smoothing spline method fits a smooth 
curve to a set of observations using a cubic function (110, 111). Specifically, given a set of 
observations of error-free read counts and shadow counts, (n1, s1), (n2, s2), …, (nm, sm), n1 < 
n2 <…< nm, we modeled the relationship between ni and si as a function 𝑠𝑖 = 𝒰(𝑛𝑖), with two 
continuous derivatives, where ni is the number of error-free read counts with sequence i, si is the 
number of shadow counts with sequence i, i = 1, …, m, and m is the total number of sequences. 
Among all such functions with two continuous derivatives, the purpose of the smoothing spline 
is to find the estimated function minimizing the penalized residual sum of squares 
∑ (𝑠𝑖 − ?̂?(𝑛𝑖))
2𝑚
1 + 𝜆 ∫ ?̂?
′′(𝑛)2𝑑𝑛
𝑛𝑚
𝑛1
, where λ is a smoothing parameter (110). We used the 
cubic smoothing spline implemented in the R function “smooth.spline” in the “stats” package 
(93). To improve the robustness of the spline, we used a robust smoothing spline approach to 
model the relationship between shadow counts (st) and error-free read counts (nt). This approach 
uses an iterative re-weighted smoothing spline algorithm with the inverse of the absolute value of 
the residuals as the weights. We used the robust smoothing spline implemented in the R function 
“robustSmoothspline” in the package “aroma.light” (112, 113). 
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Based on the fitted model of shadow counts as a spline function of error-free read counts, we 
used the definition of the per-read error rate used by Wang et al. (83). Let n1, n2, …, nm be the 
read counts of m sequences, where n1 < n2, …, nm-1 < nm, and let ?̂?1, ?̂?2, …, ?̂?m be the 
corresponding fitted values of shadow counts using the smoothing spline approaches described 
above. Given a sequence t with read count nt and fitted shadow count ?̂?t, we defined the per-read 
error rate as 
 
𝐸𝑅(𝑛𝑡) =
∑ ?̂?𝑗
𝑡
𝑗=1
∑ ?̂?𝑗
𝑡
𝑗=1 +∑ 𝑛𝑗
𝑡
𝑗=1
. 
 
Estimation of error rates using this definition also assumes the increasing number of shadows 
with the increasing number of read counts in the presence of sequencing errors, but this 
definition allows error rates to vary by read counts, whereas the Wang et al. (83) approach 
assumes the error rate to be a constant irrespective of the number of reads. For the purpose of 
comparison with the Wang et al. (83) approach, we also defined a sample per-read empirical 
error rate.  Given a sample with m sequences, we randomly sampled 1,000 numbers of read 
counts from n1 to nm and calculated the per-read error rates for each of these read counts using 
the fitted spline. The median of these per-read error rates was reported as a sample per-read 
empirical error rate (henceforth denoted as EER).  
 
 
28 
 
2.2.3 Next-Generation Sequencing Data  
  
We used next-generation sequencing data from four projects--the MicroArray Quality Control 
(MAQC) project (mRNA-seq) (105), a mutation screening study (re-sequencing) (106), the 
Encyclopedia of DNA Elements (ENCODE) project (mRNA-seq) (107), and bacteriophage PhiX 
174RF1 (PhiX) DNA samples (83)--to perform the simulations and demonstrate the accuracy of 
the proposed empirical error rate estimation approach. PhiX DNA data in FASTQ format were 
generated by the Center for Cancer Computational Biology at Dana-Farber Cancer Institute and 
provided by Wang et al. (83). The other three data sets are publicly available from the National 
Center for Biotechnology Information Sequence Read Archive (114) in FASTQ format with 
equal read lengths in each sample. All the data were converted to read counts using the shadow 
regression program provided by Wang et al. (83).  
 
2.2.3.1 MAQC Brain Experiment 2 Data 
The MAQC project was initiated to address concerns about the reliability of microarray 
technology (105). This project provided gene expression levels measured from two RNA 
samples, including a Universal Human Reference RNA from Stratagene and a Human Brain 
Reference RNA from Ambion, in four titration pools on seven microarray platforms with three 
expression methodologies. In this study, we used the sequence data from the MAQC brain 
experiment 2 (Sequence Read Archive [SRA]010153), including 14 samples on two flowcells 
(SRX016366 and SRX016368) run on the Illumina 1G Genome Analyzer with each sample 
containing ~12 million reads.  
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2.2.3.2 Mutation Screening Resequencing Data 
 
The mutation screening study provided re-sequencing data (SRA010105) from 24 patients with 
X-linked mental retardation (XLMR) for mutations in 86 previously identified XLMR genes, 
using a method that combined a novel droplet-based multiplex PCR method and next-generation 
sequencing (106). An Illumina/Solexa Genome Analzer II platform was used to perform the 
sequencing, and each sample contained ~12 million reads.  
 
2.2.3.3 ENCODE Transcriptome Data 
 
The ENCODE project used high-throughput approaches to provide a biologically more 
informative representation of the human genome (107). The ENCODE pilot phase included more 
than 200 experimental and computational data sets from 35 groups (107). In this study, we used 
the ENCODE human mRNA sequence data (SRA001150), including 5 samples of human cell 
line K562 (SRX000570) run on the Illumina 1G Genome Analyzer; each sample contained ~12 
million reads. 
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2.2.3.4 PhiX DNA Data 
The bacteriophage PhiX 174 is an icosahedral virus. It contains a closed circular single-stranded 
DNA molecule with 5,386 nucleotide bases (115). PhiX 174 was the first DNA-based genome 
for which the complete nucleotide sequence was successfully determined (115-117). In this 
study, we used two PhiX DNA samples provided by Wang et al., which were generated from the 
Center for Cancer Computational Biology at Dana-Farber (83). The PhiX DNA samples were 
sequenced using Illumina. One sample contained ~14.6 million reads, and the other contained 
~25.7 million reads.  
 
2.3 Simulation Approaches  
 
We performed simulation studies to investigate the performance of the proposed EER and 
compare it with the SRER. We used two approaches to perform the simulation: (1) Wang et al.’s 
simulation approach and (2) a new frequency-based simulation approach described below.  
 
2.3.1 Wang et al. Simulation Approach  
In the Wang et al. study (83), the simulation was conducted based on a sample from the MAQC 
brain experiment 2 (SRR037440) using calibration. The authors considered reads uniquely 
mapped to the reference genome with no mismatches as error-free reads and then added 
substitution errors based on pre-specified base-specific error rates, which were estimated from 
the sample SRR037440 by counting the number of mismatches to the reference genome at each 
base. To mimic the Wang et al. simulation procedure, we used the same sample (SRR037440) to 
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retrieve the error-free reads and estimate the pre-specified base-specific error rates. In particular, 
we retrieved ~4.4 million perfectly matched reads from the SRR037440 sample, which originally 
had ~12 million reads. We used several approaches to estimate the pre-specified base-specific 
error rates. In our first approach, we aligned the reads to the reference genome, marked the 
mismatch locations, and then calculated base-specific error rates as a percentage of the mismatch 
nucleotides at each location (Additional file 3(C)). In our second approach, we located all 
unprocessed reads for each sequence, recorded locations and numbers of mismatch nucleotides, 
and calculated the base-specific error rates from the total number of mismatch nucleotides at 
each location (Additional file 3(D)). However, we found that neither of these approaches could 
obtain the same base-specific error rates shown in the Wang et al. study. Thus, we included the 
pre-specified base-specific error rates used in their study, which we extracted approximately 
from the figures in the article (83) (Additional file 3(E)). In addition, we used the base-specific 
error rates for sample SRR037440 obtained from the shadow regression software developed by 
Wang et al. (83) as another set of pre-specified base-specific error rates (Additional file 3(F)).  
 
The Wang et al. simulation approach assumed an underlying linear relationship between the 
error-free read counts and shadow counts, no matter which base-specific error rate was used. 
Therefore, the data simulated by using the Wang et al. simulation approach would not reflect the 
non-linear relationships between error-free read counts and shadow counts (Additional file 3(A)). 
For example, in some samples, when the number of error-free read counts is low, the shadow 
counts may decrease as the error-free read counts increase. Therefore, we proposed a frequency-
based simulation approach to generate the error-free read counts and shadow counts directly, 
which can mimic the real sequence counts of the data structure.  
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2.3.2 Frequency-based Simulation Approach  
Given the counts of all sequence reads in a real sample, we followed the same procedure 
described in Wang et al. to obtain the error-free read counts (ni) and shadow counts (si) for N 
sequence reads, i = 1, 2, … N and n1 < n2, …, nN-1 < nN. We selected the top N reads with the 
highest frequencies to be the error-free reads and obtained the corresponding read counts (ni); we 
then mapped all the rest of the sequences in the sample to the error-free reads to identify the 
corresponding shadow counts (si). We used N=1,000, as suggested in Wang et al. Based on the 
read counts and shadow counts in the real sample, we first constructed a frequency table for the 
error-free read counts (ni) using pre-specified bin widths. Because in most of the samples we 
investigated, the error-free read counts became very sparse when they were large, we used 
unequal bin widths to avoid having almost empty bins. Within each bin of the error-free read 
counts, we then constructed a frequency table for the shadow counts (si) using pre-specified 
equal bin widths. Given M bins for error-free read counts and L bins for shadow counts within 
each of the error-free read count bins, the frequencies can be written as pj, j = 1, 2, …, M, for 
error-free read counts and qkj, k = 1, 2, …., L and j = 1, 2, …, M, for shadow counts. To sample a 
pair of observations (nnew, snew), we first sampled two independent random numbers, U ~ 
uniform(0, 1) and V ~ uniform(0,1). If 𝑈 ∈ [∑ 𝑝𝑖
𝑗
𝑖=1 , ∑ 𝑝𝑖
𝑗+1
𝑖=1 ), we sampled nnew ~ uniform(nj, 
nj+1), where nj and nj+1 are the endpoints for the corresponding bin j of read counts. Further, 
within the read counts bin j, if 𝑉 ∈ [∑ 𝑞𝑖𝑗
𝑘
𝑖=1 , ∑ 𝑞𝑖𝑗
𝑘+1
𝑖=1 ), we sampled snew ~ uniform(sk, sk+1), 
where sk and sk+1 are the endpoints for the corresponding bin k of shadow counts. With this 
approach, we can generate more pairs of error-free read and shadow counts (i.e., > 1,000).  
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2.3.3 Comparisons of Different Simulation Approaches 
We performed a simulation study to compare the Wang et al. simulation approach with our 
proposed frequency-based simulation approach using information from sample SRR037440 in 
Wang et al.’s study (83). Figure 1 shows the relationships between the shadow counts and error-
free read counts for the original SRR037440 sample data (panel A), as well as the simulated data 
generated using the frequency-based simulation approach (panel B) and the Wang et al. 
simulation approach using different pre-specified base-specific error rates ( as described in the 
Method; panels C-F). As expected, the data generated using the Wang et al. simulation approach 
showed that the shadow counts increase linearly as the read counts increase, which does not 
reflect the true pattern of the original data (panel A). Also, different pre-specified base-specific 
error rates had very similar performance. On the other hand, the data generated using the 
frequency-based simulation approach (panel B) showed a pattern very similar to that of the 
original data. We also plotted the fitted shadow linear regression lines, cubic smoothing spline 
curves, and robust smoothing spline curves in Figure 1 for the original and simulated data, 
respectively. It should be noted that the shadow linear regression lines and the smoothing spline 
curves performed similarly when the data were generated using the Wang et al. simulation 
approach because the approach generated data using a linear relationship. However, compared to 
the linear lines, the smoothing spline curves captured more features when both the original data 
and the data generated using the frequency-based simulation approach were used (panels A and 
B).  
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Figure 1. Sample SRR037440 from the MAQC brain experiment 2 data set and 
corresponding simulated data using frequency-based and Wang et al. simulation 
approaches  
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Figure 2. Read counts for the SRR032577 sample in the mutation screening re-
sequencing study 
 
CAAAGCAACTTATGGGACTTGGTTGGCTTCTGTTTG 22010 
CCAGACTTCTCCTCAAGTTATGCAAATCTTATGTCA 17456 
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTGAAA 14515 
ACTCATACAGGAGAGAAACCTTATGAATGCAGAGAC 13720 
GAGACAGAGCTGTAGAGAAACAAAAAGAGAAAGATG 12759 
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTAGAT 9832 
GAACAAATGCTTTTCCAACCCATGAGTGCTAAGAGC 9192 
CTCGCCATGATTATTTGACAAATAATGAGACTAGTA 7583 
GTATTCATCAAGCTGACTGGATCCATTTGTCCGGGT 7357 
GATGACAATCTCCAAGTGACATTTCACTGTGTTCCT 7039 
AGATCGGAAGAGCTCGTATGCCGTCTTCTGCTTGAA 6887 
GGTATCTAATAGCAGGGAGGAGGAAGGCCTGTTGCT 6846 
AGCAACATGCTATGAACAAAGACCCTTCTGTAACAA 6700 
GGTGATGTCCTATCACACTAAACATCGATTGGAGTG 6399 
AAGAAGCAGTTTTAGCTTCTTAGATCGGAAGAGCTC 6224 
GATAATTGAGCTGTGCATGAATGTTAACTCTTAAAA 6136 
GGTAGTGGATCTTTCTGTCTATCAAGAACAGGCCTG 6022 
GGTATGAGCTTGACTGAGAGGCCTCTCCTGACTATC 5894 
ATCACAGAATCACAAAGCTGGTAAGGAGCCTCCCAA 5702 
AGCAAACTGAAATTTTCCCATACTGAGTCATTCATG 5670 
GCAGTTCTAGTCAAGCATACAATATCCAGAACCACC 5599 
GTACATAGTAGGTGCTCGATGAATGGTTATTTCCTC 5596 
AATTTTATGACCAGGCAGTGTTAAAATTAATACTTA 5489 
GTGCTCTTTCTTGAGAAGTCTTCCAGTTATTCAACT 5361 
GTTACACAACACATGTCAGTTGCAGGGGCAGGAACT 5279 
GATTCTCTTTGCCAGCTTAGATGGCTTCGGTTTCAG 5193 
…… 
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We have also evaluated the error rates for the original sample SRR037440 and the simulated data 
generated using different simulation approaches and different error rate estimation approaches, 
including shadow linear regression (SRER), cubic smoothing spline (EER_CS), and robust 
smoothing spline (EER_RS) approaches. When the data sets were generated using the Wang et 
al. approach, the estimated error rates obtained using the different approaches were very similar 
and were close to the expected error rate, which was consistent with the results shown in Figure 
1. For example, when the first pre-specified base-specific error rate (R1) was used, the expected 
per-read error rate was 0.1308 and the estimated error rates were 0.1313, 0.1328, and 0.1319 for 
SRER, EER_CS, and EER_RS, respectively. In the data set generated using the frequency-based 
simulation approach, the approaches using smoothing splines provided more accurate 
estimations for the per-read error rates than the shadow linear regression approach: the expected 
error rate was 0.2436, and the estimated error rates were 0.1614, 0.2157, and 0.2166 for SRER, 
EER_CS, and EER_RS, respectively. 
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Table 1. Comparison of the Wang et al. and proposed frequency-based simulation 
approaches using sample SRR037440*  
 
Simulation Approaches  Expected ER SRER EER_CS EER_RS 
      
Original sample - 0.1910 0.2297 0.2409 
      
Wang et al.  
R1 0.1308 0.1313 0.1328 0.1319 
R2 0.2563 0.2548 0.2560 0.2553 
R3 0.2135 0.2149 0.2173 0.2153 
R4 0.1702 0.1692 0.1704 0.1718 
Frequency_based  0.2436 0.1614 0.2157 0.2166 
            
* For the frequency-based simulation approach, we considered the top 1,000 reads of sample SRR037440 with the highest 
frequencies as the error-free reads and generated 1,000 pairs of error-free read and shadow counts. 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
R1, R2, R3 and R4: different pre-specified base-specific error rates used in the simulation as described in the Methods section 
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Figure 3. Sample sequencing data from MAQC, Mutation Screening Re-Sequencing, 
ENCODE, and PhiX DNA data sets 
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A comparison between the Wang et al. simulation approach and our proposed frequency-based 
simulation approach, using the SRR037440 sample, showed that unlike the frequency-based 
approach, the Wang et al. simulation approach does not mimic the observed non-linear data 
relationship between error-free read and shadow counts. Therefore, we applied only the proposed 
frequency-based simulation approach in the simulation studies. We generated data based on the 
information from samples from the four data sets described above. For each sample, the median 
EER was calculated based on 1,000 replicates and compared with the median SRER. For all the 
simulations, we considered the top 1,000 reads of the sample of interest with the highest 
frequencies as the error-free reads and then determined the shadow counts accordingly, which 
were then used to generate the frequency tables for the simulations. Based on the frequency 
tables, we generated 1,000 pairs of error-free reads and shadow counts for each replicate. For the 
simulation data sets, we also defined an expected per-read error rate as ∑ 𝑠𝑖𝑖 (∑ 𝑠𝑖𝑖 + ∑ 𝑛𝑖𝑖 )⁄ , 
where si and ni are the shadow count and error-free read count, respectively, for sequence i, i = 
1, …, M. Note that M = 1,000 in the simulation studies, as we generated 1,000 pairs of error-free 
read and shadow counts. 
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2.4 Results 
 
2.4.1 Simulation Results 
 
As shown in figure 1 and table 1, using the frequency-based simulation approach can better 
capture the relationship between error-free read and shadow counts, therefore, we used this 
simulation approach to perform further simulations based on next-generation sequencing data 
from the MAQC, mutation screening, ENCODE, and PhiX DNA sample data sets. We compared 
the performance of our proposed EER approach using the cubic or robust smoothing spline 
method (EER_CS or EER_RS, respectively) with that of the SRER approach.   
 
 
2.4.1.1 Simulation Results for MAQC Data 
 
Table 2 shows the median error rates (based on 1,000 replicates) obtained using the shadow 
linear regression approach and the proposed smoothing spline approaches, based on the next-
generation sequencing data from the MAQC study. We have also reported the expected error 
rates (calculated as described above) and the estimation biases, which were calculated as the 
absolute differences between the estimated error rates and the expected error rates. For all 14 
samples of MAQC data, both smoothing spline approaches provided more accurate estimations 
of the error rates with less bias than the shadow linear regression approach. Both smoothing 
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spline approaches performed very similarly. For example, for sample SRR037452, the median 
expected error rate in the simulation was 0.3305. Using SRER, the median estimated error rate 
was 0.2578, with a bias of 0.0727 compared to the expected error rate. In contrast, EER_CS and 
EER_RS had median estimated error rates of 0.3104 and 0.3096, respectively, with biases of 
0.0201 and 0.0209, respectively. From these results, we can observe that the SRER approach 
underestimated the error rates, while the smoothing spline approaches provided more accurate 
estimated error rates.  
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Table 2.  Median error rates in MAQC data using shadow linear regression and smoothing 
spline approaches*  
 
Samples  
Expected 
ER 
SRER 
SRER 
Bias 
EER_CS 
EER_C
S Bias 
EER_R
S 
EER_RS 
Bias 
        
SRR037452 0.3305 0.2578 0.0727 0.3104 0.0201 0.3096 0.0209 
SRR037453 0.1917 0.1584 0.0333 0.1824 0.0093 0.1818 0.0099 
SRR037454 0.2354 0.1515 0.0839 0.2060 0.0294 0.2059 0.0295 
SRR037455 0.1759 0.1448 0.0311 0.1675 0.0084 0.1668 0.0091 
SRR037456 0.2312 0.1622 0.0690 0.2037 0.0275 0.2035 0.0277 
SRR037457 0.1841 0.1480 0.0361 0.1777 0.0064 0.1771 0.0070 
SRR037458 0.2653 0.2321 0.0332 0.2582 0.0071 0.2575 0.0078 
SRR037459 0.2371 0.1943 0.0428 0.2202 0.0169 0.2203 0.0168 
SRR037460 0.2530 0.2018 0.0512 0.2503 0.0027 0.2490 0.0040 
SRR037461 0.2180 0.1704 0.0476 0.2105 0.0075 0.2104 0.0076 
SRR037462 0.2443 0.1734 0.0709 0.2322 0.0121 0.2308 0.0135 
SRR037463 0.2154 0.1654 0.0500 0.2023 0.0131 0.2045 0.0109 
SRR037464 0.2624 0.1666 0.0958 0.2392 0.0232 0.2403 0.0221 
SRR037465 0.2145 0.1742 0.0403 0.2038 0.0107 0.2037 0.0108 
* Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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2.4.1.2 Simulation Results for Mutation Screening Resequencing Data 
Table 3 reports the median error rates obtained using the SRER approach and the two EER 
approaches, based on next-generation sequencing data from a mutation screening study. Similar 
to the results from the MAQC samples, all 24 mutation screening resequencing samples yielded 
error rates for the smoothing spline approaches that were more accurate than or comparable to 
the estimations of error rates for SRER. For example, in sample SRR032566, the median of the 
expected error rate in the simulation was 0.0734. Using SRER, the median of the estimated error 
rate was 0.0412, with a bias of 0.0323 compared with the expected error rate. Using the 
smoothing spline approaches, the median of the estimated error rate was 0.0705 for both 
approaches, with a very small bias of 0.0029. 
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Table 3.  Median error rates in mutation screening data using shadow linear regression 
and smoothing spline approaches*  
 
Samples  
Expected 
ER 
SRER 
SRER 
Bias 
EER_CS 
EER_C
S Bias 
EER_R
S 
EER_RS 
Bias 
        
SRR032565 0.1991 0.0493 0.1498 0.1080 0.0911 0.1082 0.0910 
SRR032566 0.0734 0.0412 0.0323 0.0705 0.0029 0.0705 0.0029 
SRR032567 0.2003 0.0542 0.1461 0.1111 0.0892 0.1111 0.0893 
SRR032568 0.2040 0.0437 0.1603 0.1057 0.0984 0.1072 0.0968 
SRR032569 0.1598 0.0509 0.1089 0.1018 0.0580 0.1014 0.0585 
SRR032570 0.0985 0.0641 0.0345 0.0959 0.0026 0.0954 0.0032 
SRR032571 0.1236 0.0575 0.0661 0.1406 0.0170 0.1406 0.0170 
SRR032572 0.1495 0.0530 0.0965 0.1181 0.0314 0.1173 0.0323 
SRR032573 0.1779 0.0912 0.0867 0.1518 0.0261 0.1506 0.0273 
SRR032574 0.0986 0.0384 0.0602 0.0626 0.0361 0.0618 0.0368 
SRR032575 0.1169 0.0839 0.0330 0.1228 0.0059 0.1227 0.0058 
SRR032576 0.1554 0.0945 0.0609 0.1887 0.0333 0.1880 0.0326 
SRR032577 0.1052 0.0694 0.0359 0.1054 0.0002 0.1055 0.0002 
SRR032578 0.1143 0.0448 0.0695 0.1077 0.0067 0.1076 0.0067 
SRR032580 0.0870 0.0619 0.0251 0.1169 0.0298 0.1163 0.0292 
SRR032581 0.0770 0.0347 0.0424 0.0752 0.0018 0.0751 0.0019 
SRR032582 0.0400 0.0041 0.0359 0.0309 0.0091 0.0310 0.0090 
SRR032583 0.1224 0.0707 0.0517 0.1279 0.0055 0.1280 0.0056 
SRR032584 0.1290 0.0540 0.0750 0.1052 0.0238 0.1032 0.0259 
SRR032586 0.0445 0.0102 0.0343 0.0287 0.0158 0.0287 0.0159 
SRR032587 0.1486 0.0786 0.0700 0.1562 0.0076 0.1552 0.0066 
SRR032588 0.1240 0.0470 0.0770 0.1024 0.0216 0.1021 0.0220 
SRR033543 0.1151 0.0587 0.0564 0.0828 0.0323 0.0832 0.0318 
SRR033544 0.1267 0.0524 0.0743 0.1086 0.0181 0.1085 0.0182 
*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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2.4.1.3 Simulation Results for ENCODE Transcriptome Data 
 
Table 4 reports the median error rates obtained using different approaches based on next-
generation sequencing data from the ENCODE study. The five samples from the ENCODE study 
had higher expected error rates than the samples in the MAQC and mutation screening studies, 
which might have been due to relatively large shadow counts that corresponded with smaller 
error-free read counts (Figure 3, C). In this situation, the smoothing spline approaches still 
performed better than shadow linear regression. For example, in sample SRR002056, the 
expected error rate was 0.3646, and the estimated error rates were 0.2906, 0.3270, and 0.3233 for 
SRER, EER_CS, and EER_RS, respectively, with biases of 0.0740, 0.0376, and 0.0413, 
respectively. 
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Table 4.  Median error rates in ENCODE data using shadow linear regression and 
smoothing spline approaches*  
 
 
Samples  
Expected 
ER 
SRER 
SRER 
Bias 
EER_CS 
EER_C
S Bias 
EER_R
S 
EER_RS 
Bias 
        
SRR002053 0.5548 0.4153 0.1395 0.4609 0.0939 0.4565 0.0983 
SRR002056 0.3646 0.2906 0.0740 0.3270 0.0376 0.3233 0.0413 
SRR002065 0.4578 0.3371 0.1207 0.3740 0.0838 0.3701 0.0877 
SRR005092 0.6300 0.4047 0.2253 0.4797 0.1503 0.4727 0.1573 
SRR005093 0.4839 0.3928 0.0911 0.4221 0.0618 0.4173 0.0666 
*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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2.4.1.4 Simulation Results for PhiX DNA Data 
 
Table 5 reports the median error rates obtained using different approaches based on the next-
generation sequencing data from two PhiX DNA samples. For both samples, the smoothing 
spline approaches provided more accurate estimations of the error rates than did shadow linear 
regression. For example, in sample 100217, the median of the expected error rate in the 
simulation was 0.0323. Using SRER, the median of the estimated error rate was 0.0250, with a 
bias of 0.0073 compared to the expected error rate. The median estimated error rate for EER_CS 
and EER_RS was 0.0315, resulting in a much smaller bias of 0.0008 for both approaches.  
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Table 5.  MedianSimulation error rates in PhiX DNA data using shadow linear regression 
and smoothing spline approaches*  
 
 
Samples  
Expected 
ER 
SRER 
SRER 
Bias 
EER_CS 
EER_CS 
Bias 
EER_RS 
EER_RS 
Bias 
        
100217 0.0323 0.0250 0.0073 0.0315 0.0008 0.0315 0.0008 
100514 0.0152 0.0143 0.0009 0.0152 0.0000 0.0152 0.0000 
*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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2.4.2 Next-Generation Sequencing Data Analysis Results 
 
We applied our smoothing spline approaches to evaluate the error rates for the next-generation 
sequencing data from MAQC, mutation screening, ENCODE and PhiX DNA samples, and 
compared error rates using our smoothing spline approaches and shadow linear regression. The 
estimated error rates are reported in Tables 6, 7, 8, and 9, respectively, for samples from the 
MAQC, mutation screening, ENCODE, and PhiX DNA data sets. From the results we can 
observe that the smoothing spline approaches always provided relatively higher estimates of the 
error rates. For example, in sample SRR037454 from MAQC (Table 5), the estimated error rates 
were 0.1596, 0.2041, and 0.2196, respectively, for SRER, EER_CS, and EER_RS. This was 
expected given that shadow linear regression tended to underestimate the error rates in the 
simulation results.   
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Table 6. Error rates in real MAQC data using shadow linear regression and smoothing 
spline approaches 
 
 
Samples  SRER EER_CS EER_RS 
    
SRR037452 0.2695 0.3124 0.3362 
SRR037453 0.1598 0.1819 0.1822 
SRR037454 0.1596 0.2041 0.2196 
SRR037455 0.1482 0.1694 0.1700 
SRR037456 0.1657 0.2062 0.2162 
SRR037457 0.1541 0.1796 0.1793 
SRR037458 0.2386 0.2573 0.2575 
SRR037459 0.1996 0.2216 0.2233 
SRR037460 0.2027 0.2504 0.2647 
SRR037461 0.1779 0.2058 0.2093 
SRR037462 0.1858 0.2329 0.2319 
SRR037463 0.1771 0.2019 0.2072 
SRR037464 0.1850 0.2377 0.2448 
SRR037465 0.1842 0.2019 0.2070 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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Table 7. Error rates in real mutation screening data using shadow linear regression and 
smoothing spline approaches  
 
 
Samples  SRER EER_CS EER_RS 
    
SRR032565 0.0753 0.1167 0.1206 
SRR032566 0.0584 0.0746 0.0745 
SRR032567 0.0846 0.1420 0.1446 
SRR032568 0.0686 0.1566 0.1566 
SRR032569 0.0597 0.1015 0.1020 
SRR032570 0.0691 0.0973 0.0954 
SRR032571 0.0724 0.1400 0.1400 
SRR032572 0.0818 0.1611 0.1593 
SRR032573 0.1602 0.2756 0.2752 
SRR032574 0.0557 0.1004 0.1053 
SRR032575 0.0882 0.1191 0.1179 
SRR032576 0.1101 0.1915 0.1899 
SRR032577 0.0762 0.1282 0.1280 
SRR032578 0.1365 0.1874 0.1873 
SRR032580 0.0727 0.1262 0.1266 
SRR032581 0.0981 0.0506 0.0511 
SRR032582 0.0941 0.1689 0.1679 
SRR032583 0.1141 0.2057 0.2042 
SRR032584 0.0849 0.0963 0.0742 
SRR032586 0.0623 0.3606 0.3621 
SRR032587 0.0857 0.1524 0.1532 
SRR032588 0.0701 0.1446 0.1440 
SRR033543 0.0802 0.1084 0.1102 
SRR033544 0.1175 0.1588 0.1586 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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Table 8. Error rates in real ENCODE data using shadow linear regression and smoothing 
spline approaches  
 
 
Samples  SRER EER_CS EER_RS 
    
SRR002053 0.4134 0.4469 0.4453 
SRR002056 0.3225 0.3020 0.3355 
SRR002065 0.3842 0.3918 0.3913 
SRR005092 0.4628 0.4884 0.4776 
SRR005093 0.4090 0.4724 0.4013 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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Table 9. Error rates in real PhiX DNA data using shadow linear regression and smoothing 
spline approaches  
 
 
Samples  SRER EER_CS EER_RS 
    
100217 0.0261 0.0317 0.0315 
100514 0.0142 0.0155 0.0157 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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2.5 Conclusion 
 
In summary, we proposed an empirical error rate estimation approach in which cubic and robust 
smoothing splines were used to model the read-shadow relationship. The proposed approach 
does not assume a linear relationship between the error-free reads and shadows counts and 
provides more accurate estimations of error rates for next-generation, short-read sequencing data 
(69). 
 
 
2.6 Discussion 
 
Next generation sequencing has enabled high throuput capacity of parallel sequencing and 
significantly driven down the cost which makes it widely employed to study various biological 
phenomena. Nonetheless, due to the high volume of short reads produced in next generation 
sequencing, the raw accuracy may impact the downstream analysis for genetic studies. 
Therefore, before performing downstream genomic analysis, it is essential to accurately assess 
the sequencing error rates. We have developed the empirical error rate estimation approach 
which provides more accurate estimation than other available approaches for assessing next 
generation sequencing data (69). 
In this chapter, we first reviewed the shadow regression error rate estimation approach (83). The 
shadow regression approach is under the linearity assumption that the number of shadows 
increases linearly with the number of error-free read counts. The linearity assumption might be 
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valid if one could obtain and plot the true error-free sequence read counts and the corresponding 
shadow counts by using only the reads containing sequencing errors. However, in practice, such 
information is not identifiable and the non-linear relationship is not rare. Sequencing data is with 
noise. It is critical to estimate the sequencing error rate more accurately and robust. We proposed 
a sample-level error rate taking the median of error rates obtained from different sets of error-
free read counts and corresponding fitted shadow read counts, which may provide more robust 
estimation (69).  
We tested the samples of next generation sequencing data presented in Wang et al. paper (4). The 
linearity assumption between the shadow read counts and the error-free read counts might hold 
in the PhiX DNA sequencing samples; however, it is not valid for the mutation screening re-
sequencing samples and the mRNA sequencing data (MAQC and ENCODE) samples after 
investigation. Therefore, we proposed to employ the non-linear statistical model to estimate the 
relationship between the error-free read counts and shadow counts using smoothing spline 
approaches. The smoothness can be controlled and adjusted via tuning parameter in the penalty 
term, which can reduce the likelihood of overfitting the data (100). Because we desired a 
smoother interpolating function, the cubic smoothing spline approach was employed in our 
chapter instead of a linear smoothing spline approach. Moreover, in order to improve the 
estimation robustness, we also proposed to employ the robust smoothing spline approach, using a 
weight equal to the inverse of the absolute value of the residuals to iteratively estimate the re-
weighted smoothing spline algorithm. In addition, to better investigate the performance of the 
proposed approach, we developed the frequency-based simulation approach, which can mimic 
the real sequence data structure more realistically than the Wang et al. simulation approach (4). 
Under the simulation studies tested, the shadow linear regression underestimated the sequencing 
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error rates, whereas the empirical error rate estimation approach provided more accurate 
estimation results. The superior performance of empirical error rate estimation approach also 
hold for the DNA sequencing data, in which the linear read-shadow relationship might be valid 
(69).  
In practice, due to polymorphisms or duplications, the true genome sequence sample might differ 
from the reference genome. Therefore, in our chapter, we investigated two additional simulation 
scenarios: (1) as was assumed in Wang et al. (83), there is one polymorphism for every 1,000 
base pairs in the sequence; and (2) there are two base-pair duplications for every 1,000 base pairs 
in the sequence, respectively. It is critical to note that these two assumptions are specific in 
simulation and are not necessary for shadow-based approaches. Specifically, we mapped the 
sample of SRR037440 to a reference and extracted the sequence reads that are uniquely mapped. 
We added one polymorphism or two base-pair duplications per 1,000 base pairs in the sequences 
and considered the resulting sequence reads as error-free sequence reads. Substitutional errors 
were then added according to the pre-specified per-base sequence error rates. After simulation 
studies tested in both scenarios, our proposed empirical error rate estimation approach provided 
more accurate estimation results. For example, in the simulation scenario under the first 
assumption that one polymorphism occurred per 1,000 base pairs, the expected error rate was 
0.1977, whereas the estimated error rates were 0.1973 and 0.1989 using the cubic smoothing 
spline and robust smoothing spline, respectively. In the simulation scenario under the assumption 
that two base-pair duplications occurred per 1,000 base pairs, the expected error rate was 0.1728. 
The estimated error rates using the cubic smoothing spline and robust smoothing spline were 
0.1722 and 0.1761, respectively. These simulation results showed that the proposed empirical 
error rate estimation approach is robust and not affected by polymorphisms or duplications as 
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well as the validity of the shadow-based approaches. 
We applied the proposed empirical error rate estimation approach to real data analysis in studies 
of MAQC, mutation screening, ENCODE, and PhiX DNA, and compared the results with those 
obtained using the shadow linear regression approach. The error rates obtained using shadow 
regression approached were relatively lower compared with the ones estimated from the 
proposed approach. For example, in the samples of MAQC mRNA sequencing study, error rates 
yielded in our approach were between ~17% and ~32%, whereas error rates provided in shadow 
regression were ~15% to ~27%. As can be seen by even simple visual inspection, the lower error 
rates yielded by shadow regression approach may be attributed to the linearity assumption that is 
not valid in some real data sets. For the DNA sequence data where the linearity assumption 
might be valid, the proposed empirical error rate estimation approach provided similar 
estimations with those obtained using shadow linear regression (69).  
 
To further investigate the performance of the proposed approach, simulation analysis was 
conducted. As the simulation approach proposed by Wang et al. (83) may not reflect the real 
sequence data structure, we developed a frequency-based simulation approach that captures the 
nonlinearity association between the number of reads containing errors and the number of error-
free reads according to sequencing read counts from real data sets. These two simulation 
approaches were compared. From on the investigation, it showed that the data generated using 
the Wang et al. simulation approach followed the pattern that the shadow sequence read counts 
increased linearly with the error-free sequence read counts which was different from the real 
sequence data structure; compared with it, the data generated using the proposed frequency-
based simulation approach mimics the real sequence data structure (69).   
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For the proposed approach, we adapted the original definition of per-read error rate that was the 
defined to be the proportion of reads containing sequencing errors among all the reads in a 
sample in Wang et al. (83). Instead of a fixed slope in the linear regression model, we re-defined 
the empirical per-read error rate as a function of error-free read counts that varies based on the 
basis of the sequence read. The proposed empirical per-read error rate could provide more 
information according to the sequence read counts compared to the original per-read error rate 
definition in Wang et al. (4) where a single fixed error rate is estimated for all the sequence reads 
in a given sample. We also defined a sample-level error rate that uses the median of the error 
rates estimated from different pair sets between the numbers of error-free read counts and 
corresponding fitted shadow counts (69).  
In the shadow-based approaches, both the proposed error rate estimation approach and shadow 
linear regression approach can be impacted by outliers. Therefore, , we suggest to pre-process 
the next generation sequence data using standard statistical analysis approaches such as boxplot 
rule approach which is based on the upper and lower quartiles of data distribution, chi-square 
analysis (118), Dixon test (119), and Grubbs’ test (120). Alternative approaches could be 
quantile regression (121) or Akima spline (122, 123) that might be more robust to outliers. In this 
chapter, we applied the proposed approaches to multiple next generation sequencing 
experiments, such as DNA sequencing, mRNA sequencing and re-sequencing data. We also 
showed that under the presence of polymorphisms and duplications, the shadow-bases 
approaches are valid. In addition, with the advantage of not requiring a reference genome in 
shadow-based approaches (i.e., shadow regression and our proposed approaches), it can be 
applicable to other types of sequencing studies, such as extensive polymorphisms, isoforms, or 
the microbiome. Specifically, the shadows (i.e., reads with errors) defined in the shadow-based 
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approaches are the sequence reads with up to two bases different from the error-free sequencing 
reads. The sequencing reads will not be counted as shadows with many differences, such as 
extensive polymorphisms, isoforms or microbiome data in the analysis (69).  
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Chapter 3 
Extension Studies of Empirical Error Rate Estimation Approach 
for Substitution, Deletion, and Insertion Sequencing Errors  
 
 
3.1 Introduction 
Despite the growing number of sequenced genomes, our knowledge of mutation rate in insertion 
and deletions (indels) has only recently started to be explored (124, 125). In comparison, SNP 
has been deeply studied in most biological processes including genetic disease, species 
divergence, genetic evolution, and adaptation. Recent study showed that indels are associated 
with these processes and play an important role as well. Previous studies revealed that insertions 
radically increase frequency of ectopic recombination, which may lead to chromosome 
instability and genetic variation. Indels are mutational components of gene and pseudogene 
evolution and play an essential role in long-term evolution of genome size. Previous studies 
compared the ratio of nucleotide substitutions to the ratio of indels and showed that indels 
dominate the early divergence process (126). In addition, indels have been shown being 
associated with human disease, apoptosis mechanisms, phenotypic change, activity of surface 
antigen (124, 127-136). Recent study also found important association between indels and 
human cancer genes. For example, Yang et al. (2010) studied the somatic mutations in cancer 
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and found that one of the most significant characteristics of cancer related mutations is the high 
frequency of indels. (137)  
 
Indels also happened to next generation sequencing data. To our knowledge, the majority 
existing sequencing error rate estimation approaches focused on substitution error rates. In 
shadow regression, the sequences containing errors were defined to be the sequences with up to 
two bases different from error free sequence reads for the short read next generation sequence 
data (4). However, the indel error rates also play an essential role that may negatively impact the 
quality of downstream genomic analysis. In genetics, sequencing deletion is a type of mutation 
that occurs when some genetic material is lost; whereas sequencing insertion occurs when extra 
genetic material inserted to a sequence (138, 139). 
Conventional approaches (140-143) to study indels using a reference genome has the limitation 
when sequence a new genome as it may not be available to find a well-established reference for 
the new genome. It is critical to estimate the sequencing error rates more accurate and for more 
diverse sequencing error definitions including different bases in substitution, insertion, and 
deletion for next generation sequencing data. In this study, we extend the shadow definition by 
different bases in substitution and also study the indels without using reference based on the 
study in Wang et al. (4). 
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3.2 Method 
In both previous chapter and shadow regression study to estimate short read sequencing error 
rates, the shadows were the sequences with up to two bases different from error-free reads for 
short reads sequencing data by substitution (4, 69). To better investigate the performance of the 
empirical error rate estimation approach (69) in more diverse scenarios, in this chapter, I adjusted 
the original shadow definition (4) to different bases of substitution, deletion, and insertion, 
respectively. Empirical error rate estimation approach was applied to multiple sequencing data in 
both simulation study and real data analysis, and compared with the estimation results obtained 
from shadow regression approach.  
Shadows were the sequences containing errors. Different definitions of shadow would lead to 
different quality assessment results for next generation sequencing data. Based on Wang et al. 
(4), using shadows defined as sequence reads with up to two bases different from error-free reads 
provides enough estimation accuracy without excessive computational cost. In order to validate 
this statement, I adjusted the shadow definition to be only one base different, only two base 
different, only three bases different, and up to three bases different from error-free sequences in 
substitution, respectively.  
As described in Chapter 2, both the empirical error rate estimation approach and shadow 
regression approach do not require using a reference genome. In the shadow-based approaches, 
the frequency of each sequence was first calculated according to the sequence read counts. Based 
on the frequency of each sequence read, the top 1000 sequences with the highest frequencies 
were selected as the error-free sequence reads (4, 69). All the possible sequences with only one 
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base different, only two bases different, only three bases different, up to two bases different, and 
up to three bases different from error-free reads in substitution were set out and generated as 
pseudo shadows, respectively. The corresponding pseudo shadows were then mapped to the 
remaining sequence reads that have not been selected as error-free sequences in the sample, to 
obtain the number of shadows of only one base different, only two bases different, only three 
bases different, up to two bases different, and up to three bases different from error-free reads in 
substitution for each sequence read. In this way, we can obtain the number of error-free 
sequences and corresponding shadow counts in different shadow definitions accordingly.  
I applied the empirical error rate estimation approach using smoothing spline and robust 
smoothing spline data samples in DNA (sample 100217) and mRNA (sample SRR002053, 
SRR032586, SRR037456) and compared the results with those obtained from shadow regression 
approach to estimate the error rates in different substitution shadow definitions.  
In addition to substitution, I also extent the study to deletion error rates. The shadows for 
deletion were computed differently from those by substitution. In the sequences data we were 
investigating, all the sequence reads are with the same lengths. Specifically, given a particular 
read in the sample, if one base is deleted from the original sequence, an extra base would be 
added to the end of the read to keep the length of number of bases in each sequence.  
There are three approaches to count the deletion shadows in this study, which are left side 
deletion, right side deletion, and two-side deletion, respectively. In a forward direction sequence, 
suppose there is a base deleted from the original sequence, given that all the sequences are with 
the same lengths, the left side deletion is to add the extra base to the left end side of the read with 
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one of the four possible alleles (“A”, “T”, “G”, and “C”). Another way to estimate the deletion 
error rate is the right side deletion. In a forward direction sequence, the right side deletion error 
occurs when there is a base deleted from the original sequence, an extra base is added to the right 
end side of the read with one of the four possible alleles (“A”, “T”, “G”, and “C”). Furthermore, 
the third deletion error rate is two-side deletion. When one base is deleted from the original 
sequence, if the extra base is added to either left end side or right end side of the read, we called 
it two-side deletion. For example, given that the original sequence is ATGAC and all the 
sequences are with the same length, if the 3rd base was deleted, then the remaining sequence 
read would be ATAC. Since there were four passible alleles (“A”, “T”, “G”, and “C”), then the 
left side deletion is to add the extra base to the left side resulting the possible shadows as 
AATAC, TATAC, GATAC, and CATAC. The possible shadows in the right side deletion 
approach would then become ATACA, ATACT, ATACG, and ATACC. Moreover, for two side 
deletion, the possible shadows would become AATAC, TATAC, GATAC, CATAC, ATACA, 
ATACT, ATACG, and ATACC. 
In addition to deletion and substitution errors, the third type of sequencing error refers to 
insertion. There are three types of sequencing insertion, which are left side insertion, right side 
insertion, and two-side insertion. In the data we investigated, all the sequences are with the same 
lengths. Suppose there is a base inserted into the original sequence, then an extra base will be 
removed from the end of the original sequence read. In a forward direction sequence, if the extra 
base is removed from the right end side, this insertion is defined as left side insertion. The base 
inserting to the last base in a forward sequence direction is not accounted for the left side 
insertion. The second type of insertion is right side insertion that supposing there is a base 
inserted to the original sequence, then an extra base will be removed from the left end side to 
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keep the sequence length same over all the sequences. In the right side insertion, the base 
inserting to the first base in a forward sequence direction is not accounted. In addition, there is 
also a two-side insertion approach, which refers to the scenario when a base inserted into the 
original sequence, given all the sequences are with the same lengths, an extra base removed from 
either left end side or right end side of the read.  
I applied simulation study as in Chapter 2 and real data analysis using empirical error rate 
estimation approach and compared the results with those obtained from shadow regression 
approach with the use of different shadow definitions to investigate the performance of the 
proposed empirical approach.  
 
 
3.3 Result 
In order to better understand the error rate estimation performances when shadows varied, 
simulation studies were investigated for deletion and insertion error rates for different shadows 
of only one base different, only two bases different, and up to two bases different using empirical 
error rate estimation approach, and compared with the results from shadow regression approach.  
 
Deletion error rates from left side, right side, and two sides in the simulation studies were 
investigated. Table 10 shows the median deletion error rates from simulation study based on the 
next-generation sequencing data samples, for shadows defining to be only one base different, 
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only two bases different, and up to two bases different from error-free sequences, (based on 
1,000 replicates) obtained using the shadow regression approach and the proposed empirical 
error rate estimation approaches. The expected error rates was calculated as 
∑ 𝑠𝑖𝑖 (∑ 𝑠𝑖𝑖 + ∑ 𝑛𝑖𝑖 )⁄ , where 𝑠𝑖 and 𝑛𝑖 are the shadow count and error-free read count, 
respectively, for sequence i, i = 1, …, M, and M = 1,000 in the simulation studies, where we 
generated 1,000 pairs of error-free read and shadow counts (69). The estimation biases were 
calculated as the absolute differences between the estimated error rates and the expected error 
rates.  
The empirical error rate estimation approaches provided more accurate error rate estimations 
with less bias than the shadow regression approach. Both empirical error rate estimation 
approaches using cubic smoothing spline and robust smoothing spline performed very similarly. 
For example, for sample SRR037452, the median expected left side deletion error rate with only 
one base different from error-free sequences in the simulation was 0.0453. Using SRER, the 
median estimated error rate was 0.0072, with a bias of 0.0382 compared to the expected error 
rate. In contrast, EER_CS and EER_RS had median estimated error rates of 0.0354 and 0.0351, 
respectively, with biases of 0.0099 and 0.0102, respectively. From these results, we can observe 
that the SRER approach underestimated the error rates, while the smoothing spline approaches 
provided more accurate estimated error rates.   
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Table 10 Simulation studies for deletion by testing shadows to be only 1 base, only 2 bases, 
and up to 2 bases deletion. 
 
Shadow Deletion Per-read ER SRR037452 SRR037456 SRR002053 SRR032586 
only 1 
deletion 
left side 
Expected ER 0.0453 0.0430 0.0622 0.0013 
SRER 0.0072 0.0042 0.0080 0.0001 
SRER Bias 0.0382 0.0387 0.0542 0.0012 
EER-CS 0.0354 0.0304 0.0337 0.0006 
EER-CS Bias 0.0099 0.0125 0.0285 0.0007 
EER-RS 0.0351 0.0306 0.0329 0.0006 
EER-RS Bias 0.0102 0.0124 0.0293 0.0007 
       
only 2 
deletion 
left side 
Expected ER 0.0250 0.0206 0.0423 0.0008 
SRER 0.0018 0.0006 0.0036 0.0000 
SRER Bias 0.0232 0.0200 0.0387 0.0008 
EER-CS 0.0178 0.0142 0.0197 0.0003 
EER-CS Bias 0.0072 0.0064 0.0226 0.0005 
EER-RS 0.0180 0.0146 0.0188 0.0003 
EER-RS Bias 0.0069 0.0060 0.0236 0.0005 
       
up to 2 
deletion 
left side 
Expected ER 0.0659 0.0581 0.1010 0.0020 
SRER 0.0113 0.0065 0.0141 0.0001 
SRER Bias 0.0545 0.0516 0.0869 0.0019 
EER-CS 0.0513 0.0424 0.0543 0.0008 
EER-CS Bias 0.0146 0.0157 0.0467 0.0011 
EER-RS 0.0508 0.0424 0.0515 0.0008 
EER-RS Bias 0.0150 0.0157 0.0496 0.0011 
       
only 1 
deletion 
right side 
Expected ER 0.0647 0.0640 0.1886 0.0032 
SRER 0.0124 0.0082 0.0246 0.0003 
SRER Bias 0.0523 0.0558 0.1640 0.0029 
EER-CS 0.0507 0.0473 0.1028 0.0022 
EER-CS Bias 0.0140 0.0167 0.0858 0.0009 
EER-RS 0.0503 0.0474 0.1006 0.0022 
EER-RS Bias 0.0144 0.0166 0.0880 0.0009 
       
only 2 
deletion 
right side 
Expected ER 0.1352 0.1303 0.2482 0.0043 
SRER 0.0205 0.0232 0.0425 0.0003 
SRER Bias 0.1147 0.1072 0.2058 0.0040 
EER-CS 0.1004 0.1024 0.1455 0.0028 
EER-CS Bias 0.0348 0.0280 0.1027 0.0015 
EER-RS 0.1011 0.1023 0.1427 0.0028 
EER-RS Bias 0.0341 0.0280 0.1055 0.0015 
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up to 2 
deletion 
right side 
Expected ER 0.1808 0.1765 0.3615 0.0073 
SRER 0.0406 0.0374 0.0693 0.0008 
SRER Bias 0.1402 0.1391 0.2922 0.0065 
EER-CS 0.1419 0.1398 0.2222 0.0050 
EER-CS Bias 0.0389 0.0367 0.1394 0.0023 
EER-RS 0.1416 0.1391 0.2195 0.0050 
EER-RS Bias 0.0392 0.0374 0.1421 0.0023 
       
only 1 
deletion 
two sides 
Expected ER 0.0956 0.0924 0.2162 0.0037 
SRER 0.0172 0.0124 0.0246 0.0003 
SRER Bias 0.0784 0.0799 0.1916 0.0034 
EER-CS 0.0753 0.0680 0.1119 0.0023 
EER-CS Bias 0.0203 0.0244 0.1043 0.0014 
EER-RS 0.0745 0.0678 0.1098 0.0023 
EER-RS Bias 0.0211 0.0246 0.1064 0.0014 
       
only 2 
deletion 
two sides 
Expected ER 0.1974 0.1922 0.3041 0.0051 
SRER 0.0292 0.0261 0.0368 0.0003 
SRER Bias 0.1682 0.1661 0.2674 0.0047 
EER-CS 0.1472 0.1469 0.1613 0.0031 
EER-CS Bias 0.0502 0.0453 0.1428 0.0020 
EER-RS 0.1479 0.1466 0.1576 0.0031 
EER-RS Bias 0.0495 0.0457 0.1466 0.0020 
       
up to 2 
deletion 
two sides 
Expected ER 0.2576 0.2511 0.4177 0.0085 
SRER 0.0555 0.0433 0.0611 0.0008 
SRER Bias 0.2022 0.2079 0.3566 0.0077 
EER-CS 0.2016 0.1966 0.2411 0.0055 
EER-CS Bias 0.0560 0.0545 0.1766 0.0030 
EER-RS 0.2021 0.1956 0.2373 0.0056 
EER-RS Bias 0.0556 0.0556 0.1804 0.0030 
*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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Table 11 reports the median insertion error rates from simulation study for shadows defining to 
be only one base different, only two bases different, and up to two bases different from error-free 
sequences, obtained using the SRER approach and the two EER approaches, based on next-
generation sequencing data samples. Insertion error rates from left side, right side, and two sides 
in the simulation studies were investigated. Similar to the simulation results from the deletion 
investigation, all samples in the insertion studies yielded error rates for the smoothing spline 
approaches that were more accurate than the estimations of error rates for SRER. For example, in 
sample SRR037452, the median of the left side insertion expected error rate with shadows 
defined as sequences of up to two bases different from error-free sequence reads in the 
simulation was 0.1930. Using SRER, the median of the estimated error rate was 0.0197, with a 
bias of 0.1733 compared with the expected error rate. Using the smoothing spline approaches, 
the median of the estimated error rates were 0.1689 for cubic smoothing spline with a very small 
bias of 0.0241, and 0.1783 for robust smoothing spline with a bias of 0.0147, respectively.  
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Table 11 Simulation studies for insertion by testing shadow to be only 1 base insertion, only 
2 bases insertion, and up to 2 bases insertion. 
 
Shadow Insertion Per-read ER SRR037452 SRR037456 SRR002053 SRR032586 
only 1 
insertion 
left side 
Expected ER 0.1192 0.0886 0.1692 0.0028 
SRER 0.0125 0.0056 0.0204 0.0002 
SRER Bias 0.1067 0.0830 0.1487 0.0026 
EER-CS 0.1029 0.0581 0.0873 0.0022 
EER-CS Bias 0.0163 0.0305 0.0819 0.0006 
EER-RS 0.1068 0.0579 0.0854 0.0022 
EER-RS Bias 0.0124 0.0306 0.0838 0.0006 
       
only 2 
insertion 
left side 
Expected ER 0.1141 0.0856 0.1412 0.0027 
SRER 0.0122 0.0009 0.0109 0.0001 
SRER Bias 0.1019 0.0848 0.1303 0.0026 
EER-CS 0.0987 0.0490 0.0566 0.0015 
EER-CS Bias 0.0154 0.0366 0.0846 0.0012 
EER-RS 0.1091 0.0462 0.0612 0.0015 
EER-RS Bias 0.0051 0.0395 0.0799 0.0012 
       
up to 2 
insertion 
left side 
Expected ER 0.1930 0.1554 0.2682 0.0053 
SRER 0.0197 0.0083 0.0368 0.0003 
SRER Bias 0.1733 0.1471 0.2313 0.0050 
EER-CS 0.1689 0.1002 0.1452 0.0037 
EER-CS Bias 0.0241 0.0552 0.1230 0.0016 
EER-RS 0.1783 0.0962 0.1398 0.0037 
EER-RS Bias 0.0147 0.0593 0.1284 0.0016 
       
only 1 
insertion 
right side 
Expected ER 0.1532 0.1460 0.1501 0.0020 
SRER 0.0240 0.0182 0.0182 0.0002 
SRER Bias 0.1292 0.1278 0.1319 0.0018 
EER-CS 0.1217 0.1058 0.0805 0.0011 
EER-CS Bias 0.0315 0.0402 0.0695 0.0009 
EER-RS 0.1214 0.1056 0.0778 0.0011 
EER-RS Bias 0.0318 0.0404 0.0723 0.0009 
       
only 2 
insertion 
right side 
Expected ER 0.1573 0.1538 0.1892 0.0018 
SRER 0.0262 0.0043 0.0325 0.0001 
SRER Bias 0.1311 0.1495 0.1566 0.0016 
EER-CS 0.1217 0.1006 0.1188 0.0008 
EER-CS Bias 0.0356 0.0532 0.0704 0.0009 
EER-RS 0.1237 0.1011 0.1147 0.0008 
EER-RS Bias 0.0336 0.0527 0.0745 0.0009 
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up to 2 
insertion 
right side 
Expected ER 0.2677 0.2537 0.2924 0.0035 
SRER 0.0554 0.0317 0.0494 0.0004 
SRER Bias 0.2123 0.2220 0.2430 0.0031 
EER-CS 0.2173 0.1841 0.1808 0.0019 
EER-CS Bias 0.0504 0.0696 0.1116 0.0016 
EER-RS 0.2170 0.1861 0.1770 0.0019 
EER-RS Bias 0.0507 0.0676 0.1154 0.0016 
       
only 1 
insertion 
two sides 
Expected ER 0.2245 0.2074 0.2385 0.0039 
SRER 0.0330 0.0237 0.0166 0.0003 
SRER Bias 0.1915 0.1838 0.2219 0.0036 
EER-CS 0.1737 0.1533 0.1082 0.0027 
EER-CS Bias 0.0509 0.0541 0.1303 0.0012 
EER-RS 0.1759 0.1532 0.1047 0.0027 
EER-RS Bias 0.0486 0.0542 0.1338 0.0012 
       
only 2 
insertion 
two sides 
Expected ER 0.2521 0.2316 0.3539 0.0053 
SRER 0.0590 0.0286 0.0349 0.0004 
SRER Bias 0.1930 0.2031 0.3190 0.0049 
EER-CS 0.2251 0.1706 0.1759 0.0030 
EER-CS Bias 0.0270 0.0610 0.1780 0.0023 
EER-RS 0.2310 0.1707 0.1711 0.0030 
EER-RS Bias 0.0211 0.0609 0.1828 0.0023 
       
up to 2 
insertion 
two sides 
Expected ER 0.3834 0.3577 0.4631 0.0089 
SRER 0.0873 0.0557 0.0498 0.0008 
SRER Bias 0.2961 0.3019 0.4133 0.0080 
EER-CS 0.3319 0.2783 0.2509 0.0056 
EER-CS Bias 0.0515 0.0794 0.2122 0.0032 
EER-RS 0.3321 0.2782 0.2467 0.0057 
EER-RS Bias 0.0513 0.0795 0.2164 0.0032 
*Based on 1,000 replicates. The frequency-based simulation approach was applied. For each replicate, we considered the 
top 1,000 reads with the highest frequencies as the error-free reads and generated 1,000 pairs of error-free read counts 
and shadow counts. 
 
 
Expected ER: expected error rate in simulation studies 
SRER: error rate estimated using shadow regression 
SRER Bias: the absolute value of the difference between SRER and Expected ER 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_CS Bias: the absolute value of the difference between EER_CS and Expected ER 
EER_RS: empirical error rate estimated using robust smoothing spline 
EER_RS Bias: the absolute value of the difference between EER_RS and Expected ER 
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In order to know the error rates by varying shadow definitions, the real data analysis is 
performed. Table 12 shows the error rates in real data analysis obtained using shadow linear 
regression approach and empirical error rate approach in smoothing spline and robust smoothing 
spline when shadows are defined to be only one base different, only two bases different, only 
three bases different, up to two bases different, and up to three bases different from error-free 
reads in substitutions.  The sample 100217 is a PhiX DNA sample, which were generated from 
the Center for Cancer Computational Biology at Dana-Farber and provided by Wang et al. (4). 
The PhiX 174 is an icosahedral virus containing a closed circular single-stranded DNA (144). 
The sample SRR002053 is a sample from ENCODE project transcriptome data with around 12 
million reads.  Sample SRR002053 is human mRNA sequence data from human cell line K562 
running on Illumina 1G Genome Analyzer(145). The sample SRR037452 and sample 
SRR037456 are mRNA data from MAQC brain experiment 2, which contains about 12 million 
reads for each sample (145). The sample SRR032586 is mutation screening resequencing data 
from patient with X-linked mental retardation (XLMR) for mutations in 86 previously identified 
XLMR genes(145). Sample SRR032586 was applied to data analysis study after the outliers 
were removed in Table 12.  
From the results in Table 12, the error rates of only one base different are generally greater than 
the ones of only two bases different. The error rates of only two bases different are generally 
greater than the ones of only three bases different. For example, in sample 100217, the estimated 
error rates by shadow regression were 0.0246, 0.0015, and 0.0004 for only one, only two, only 
three bases different in substitution, respectively. The error rates were 0.0289, 0.0030, and 
0.0011 by using cubic smoothing spline, and 0.0289, 0.0030, and 0.0012 by using robust 
smoothing spline, for only one, only two, only three bases different in substitution, respectively. 
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Based on previous studies (4, 146), using shadows with up to two bases different provides 
accurate estimation without too much computational cost. Using shadow with up to three bases 
different may have higher possibility of identifying more errors, but it may also count 
polymorphism as sequence errors and take excessive computational cost. In addition, the error 
rates with up to two bases different from error-free reads in substitution are similar with the ones 
of up to three bases different. For example, in sample 100217, the estimated error rates were 
0.0261 for up to two bases different, and 0.0251 for up to three bases different using shadow 
regression, and 0.0317 for up to two bases different, and 0.0322 for up to three bases different 
using cubic smoothing spline, and 0.0315 for up to two bases different and 0.0322 for up to three 
bases different using robust smoothing spline, respectively. Therefore, we confirmed with 
previous studies that using the shadow with up to two bases different is good enough without 
excessive computational cost.  
 
  
74 
 
Table 12. Real data application for substitution by varying shadow to be only 1 base 
different, only 2 bases different, only 3 bases different, up to 2 bases different, and up to 3 
bases different.  
 
 
Samples 
Substitution ER 
Estimation 
only 1 only2 only3 sub2 sub3 
100217 
SRER 0.0246 0.0015 0.0004 0.0261 0.0251 
EER-CS 0.0289 0.003 0.0011 0.0317 0.0322 
EER-RS 0.0289 0.003 0.0012 0.0315 0.0322 
       
SRR002053 
SRER 0.2832 0.2344 0.178 0.4134 0.269 
EER-CS 0.369 0.2945 0.2303 0.4469 0.4308 
EER-RS 0.3084 0.2868 0.2252 0.4453 0.4266 
       
SRR032586 
SRER 0.0707 0.0113 0.0054 0.0954 0.0696 
EER-CS 0.1199 0.0689 0.0659 0.1729 0.1353 
EER-RS 0.1193 0.0684 0.0663 0.1725 0.1386 
       
SRR037456 
SRER 0.1238 0.0548 0.0331 0.1657 0.1451 
EER-CS 0.1538 0.085 0.0624 0.2062 0.2413 
EER-RS 0.1605 0.1126 0.092 0.2162 0.2751 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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Table 13 shows the error rates from real data analysis result in deletion. Different deletion error 
rates were investigated by defining the shadows to be only one base different, only two bases 
different, and up to two bases different in left side deletion, right side deletion, and two side 
deletion, respectively. For sample SRR037452, when the shadow is defined to be only one base 
different from error-free read in deletion, the error rates from left side deletion is 0.0121, 0.0386, 
and 0.0404 using shadow regression, cubic smoothing spline, and robust smoothing spline, 
respectively. When the shadow is defined to be only two bases deletion, the error rates of left 
side deletion for sample SRR037452 is 0.0037, 0.0185 and 0.0348 using shadow regression, 
cubic smoothing spline, and robust smoothing spline, respectively. When the shadow is defined 
to be up to two bases different from error-free reads in deletion, the error rates of left side 
deletion for sample SRR037452 is 0.0184, 0.0550 and 0.0782 using shadow regression, cubic 
smoothing spline, and robust smoothing spline, respectively. The right side deletion is the 
deletion adding the extra base to the right end side of the read when some base is deleted from 
the original sequence, given that all the sequences are with the same lengths. The right side 
deletion is relatively greater than the left side deletion in the samples studied. For sample 
SRR037452, when the shadow is defined to be only one base in deletion, the error rates of right 
side deletion is 0.0201, 0.0573, and 0.0687 by using shadow regression, cubic smoothing spline, 
and robust smoothing spline, respectively. When the shadow is defined to be only two bases 
different in deletion, the error rates of right side deletion for sample SRR037452 is 0.0318, 
0.1118 and 0.1120 by using shadow regression, cubic smoothing spline, and robust smoothing 
spline, respectively. When the shadow is defined to be up to two bases deletion, the error rates of 
right side deletion for sample SRR037452 is 0.0680, 0.1559, and 0.1684 by using shadow 
regression, cubic smoothing spline, and robust smoothing spline, respectively. Another way of 
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deletion is two-side deletion. Suppose one or two bases are deleted from an original sequence 
read, given that all the sequences are with the same lengths, an extra base from one of the alleles 
(“A”, “T”, “G”, “C”) will be added to either left or right end side of the read. For sample 
SRR037452, the error rates for only one base in two-side deletion are 0.0288, 0.0829, and 0.0910 
using shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. 
When the deletion shadow is defined to be only two bases different from error-free reads, the 
error rates of two-side deletion for sample SRR037452 are 0.0439, 0.1635, and 0.1639 by using 
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. When the 
deletion shadow is defined to be up to two bases different from error-free sequences, the error 
rates of two-side deletion for sample SRR037452 are 0.0876, 0.2213, and 0.2269 by using 
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. 
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Table 13. Real data application for deletion by varying shadow to be only 1 base deletion, 
only 2 bases deletion, and up to 2 bases deletion. 
 
 
Shadow Deletion Per-read ER SRR037452 SRR037456 SRR002053 SRR032586 
only 1 
deletion 
left side 
SRER 0.0121 0.0082 0.0307 0.0028 
EER-CS 0.0386 0.0352 0.0505 0.0136 
EER-RS 0.0404 0.0386 0.0519 0.0121 
  
 
    
only 2 
deletion 
left side 
SRER 0.0037 0.0023 0.0151 0.0002 
EER-CS 0.0185 0.0139 0.0294 -0.0277 
EER-RS 0.0348 0.0198 0.0381 -0.0223 
       
up to 2 
deletion 
left side 
SRER 0.0184 0.0124 0.0475 0.0030 
EER-CS 0.0550 0.0472 0.0761 0.0080 
EER-RS 0.0782 0.0587 0.0866 0.0078 
       
only 1 
deletion 
right side 
SRER 0.0201 0.0143 0.0674 0.0045 
EER-CS 0.0573 0.0557 0.1311 0.1224 
EER-RS 0.0687 0.0637 0.1332 0.1157 
       
only 2 
deletion 
right side 
SRER 0.0318 0.0365 0.1147 0.0035 
EER-CS 0.1118 0.1109 0.1834 0.0880 
EER-RS 0.1120 0.1126 0.1794 0.0835 
       
up to 2 
deletion 
right side 
SRER 0.0680 0.0596 0.1752 0.0140 
EER-CS 0.1559 0.1539 0.2670 0.1823 
EER-RS 0.1684 0.1634 0.2645 0.1778 
       
only 1 
deletion 
two sides 
SRER 0.0288 0.0217 0.0681 0.0052 
EER-CS 0.0829 0.0792 0.1434 0.1190 
EER-RS 0.0910 0.0861 0.1426 0.1181 
       
only 2 
deletion 
two sides 
SRER 0.0439 0.0482 0.0931 0.0045 
EER-CS 0.1635 0.1627 0.1991 0.0276 
EER-RS 0.1639 0.1623 0.1967 0.0266 
       
up to 2 
deletion 
two sides 
SRER 0.0876 0.0777 0.1558 0.0159 
EER-CS 0.2213 0.2158 0.2855 0.1406 
EER-RS 0.2269 0.2219 0.2816 0.1378 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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Table 14 shows the insertion error rates from real data analysis by using shadow regression, 
cubic smoothing spline, robust smoothing spline and varying definition of insertion shadows to 
be only one base different, only two bases different, and up to two bases different from error-free 
sequences. The left side insertion is the insertion when some base is inserted from an original 
sequence, given that all the sequences are with the same length, an extra base is then removed 
from the right end side of the read. For sample SRR037452, when the shadow is defined to be 
only one base in insertion, the error rates of left side insertion is 0.0137, 0.1064, and 0.1267 by 
using shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. 
When the insertion shadow is defined to be only two bases different from error-free reads, the 
error rates of left side insertion for sample SRR037452 is 0.0032, 0.0797, and 0.1367 by using 
shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. When the 
shadow is defined to be up to two bases insertion, the error rates of left side insertion for sample 
SRR037452 is 0.0234, 0.1682, and 0.2209 using shadow regression, cubic smoothing spline, and 
robust smoothing spline, respectively. The right side insertion is the insertion when some base is 
inserted from an original sequence, given that all the sequences are with the same length, an 
extra base is removed from the left end side of the read.  For sample SRR037452, when the 
shadow is defined to be only one base in insertion, the error rates of right side insertion is 
0.0417, 0.1275, and 0.1472 using shadow regression, cubic smoothing spline, and robust 
smoothing spline, respectively. When the insertion shadow is defined to be only two bases 
difference, the error rates of right side insertion for sample SRR037452 is 0.0405, 0.1284, and 
0.1534 using shadow regression, cubic smoothing spline, and robust smoothing spline, 
respectively. When the insertion shadow is defined to be up to two bases difference, the error 
rates of right side insertion for sample SRR037452 is 0.0847, 0.2254, and 0.2581 by using 
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shadow regression, cubic smoothing spline, and robust smoothing spline, respectively. Another 
way of insertion is two-side insertion. Suppose one or two bases are inserted to a sequence read, 
given that all the sequences are with the same lengths, extra base(s) will be removed from either 
left or right end side of the read. For sample SRR037452, the error rates for only one base 
difference of two-side insertion approach are 0.0381, 0.1502, and 0.1631 by using shadow 
regression, cubic smoothing spline, and robust smoothing spline, respectively. When the shadow 
is defined to be only two bases difference, the error rates of two-side insertion for sample 
SRR037452 are 0.0045, 0.1008, and 0.1569 using shadow regression, cubic smoothing spline, 
and robust smoothing spline, respectively. When the shadow is defined to be up to two bases 
difference, the error rates of two-side insertion for sample SRR037452 are 0.0463, 0.2222,and 
0.2656 by using shadow regression, cubic smoothing spline, and robust smoothing spline, 
respectively. 
 
  
80 
 
Table 14. Real data application for insertion by varying shadow to be only 1 base insertion, 
only 2 bases insertion, and up to 2 bases insertion. 
 
 
Shadow Insertion Per-read ER SRR037452 SRR037456 SRR002053 SRR032586 
only 1 insertion left side 
SRER 0.0137 0.0085 0.0539 0.0017 
EER-CS 0.1064 0.0604 0.1113 0.0332 
EER-RS 0.1267 0.0813 0.1123 0.0289 
  
 
    
only 2 insertion left side 
SRER 0.0032 0.0035 0.0364 0.0024 
EER-CS 0.0797 0.0454 0.0884 -0.0022 
EER-RS 0.1367 0.0822 0.0407 -0.0004 
       
up to 2 insertion left side 
SRER 0.0234 0.0137 0.0937 0.0039 
EER-CS 0.1682 0.0945 0.1774 0.0275 
EER-RS 0.2209 0.1484 0.1446 0.0279 
   
    
only 1 insertion right side 
SRER 0.0417 0.0289 0.0538 0.0024 
EER-CS 0.1275 0.1157 0.1040 0.0235 
EER-RS 0.1472 0.1161 0.1045 0.0236 
       
only 2 insertion right side 
SRER 0.0405 0.0267 0.0945 0.0007 
EER-CS 0.1284 0.1124 0.1494 0.0132 
EER-RS 0.1534 0.1389 0.1600 0.0144 
       
up to 2 insertion right side 
SRER 0.0847 0.0592 0.1512 0.0056 
EER-CS 0.2254 0.2028 0.2202 0.0362 
EER-RS 0.2581 0.2218 0.2286 0.0393 
       
only 1 insertion two sides 
SRER 0.0381 0.0248 0.0505 0.0025 
EER-CS 0.1502 0.1089 0.1237 0.0546 
EER-RS 0.1631 0.1238 0.1265 0.0470 
       
only 2 insertion two sides 
SRER 0.0045 0.0033 0.0435 0.0027 
EER-CS 0.1008 0.0681 0.1131 0.0003 
EER-RS 0.1569 0.1052 -0.0045 0.0021 
       
up to 2 insertion two sides 
SRER 0.0463 0.0349 0.0970 0.0043 
EER-CS 0.2222 0.1578 0.2050 0.0458 
EER-RS 0.2656 0.2021 0.1298 0.0449 
 
SRER: error rate estimated using shadow regression 
EER_CS: empirical error rate estimated using cubic smoothing spline 
EER_RS: empirical error rate estimated using robust smoothing spline 
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3.4 Conclusion 
 
The empirical error rate estimation approach for insertion and deletion do not require using a 
reference genome in estimating sequencing error rates and are also adjustable to various base 
error estimation for next generation sequencing data. We estimated the substitution error rates by 
varying different bases and confirm that using shadows of up to two base different is good 
enough for short read sequences without excessive computational cost. We performed simulation 
studies and investigated the performance of empirical error rate estimation approaches when 
defining shadows to be deletion and insertion with only one base different, only two bases 
different, and up to two bases different from error-free sequences for left side, right side, two 
sides approaches, respectively, and compared with the results using shadow regression approach. 
Under the simulation scenarios tested, the empirical error rate estimation approach using splines 
provided more accurate estimation for both insertion and deletion error rates with less bias than 
the shadow regression approach. The proposed empirical error rate approaches were also applied 
to real data analysis and compared with the shadow regression approach.  
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Chapter 4 
Statistical Approaches for Processing and Analyzing 
Microbiome Data 
 
 
 
 
4. 1. Introduction 
 
The human microbiome refers to the totality of all microbes consisting of prokaryotes (bacteria), 
archaea, fungi, and viruses in and on the human body (147). Microbiomes rarely live alone in 
nature as they function in a complex microbial community by processing energy and materials or 
constituting an extended human genome (148, 149). The human microbial partners carry out a 
number of metabolic reactions that are essential for human health, but are not encoded in the 
human genome (150)[150].  
 
Advances in sequencing technology have allowed us to generate large amounts of microbiome 
data. Sequencing of the microbiome provides a great opportunity to assess the organismal and 
functional novelty to be discovered, which plays an essential role in human health and disease 
(150)[150]. The composition of the human microbiome varies as a result of one’s health, diet, 
lifestyle, social interactions, early antibiotic therapy, genotype, and environmental chemicals 
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(148, 151). In addition, the microbiome produces beneficial compounds in our body such as 
vitamins and anti-inflammatories that our human genome cannot produce (152). The 
relationships between components of the microbiome are often referred to as commensal, where 
one partner benefits and the other is apparently unaffected, as opposed to mutualistic, where both 
partners experience increased fitness (149). Recent studies have shown the microbiome to be 
associated with complex diseases, including obesity (51), cardiovascular disease (153), type 2 
diabetes (51), and colorectal cancer (154). Also, the gut microbiome was shown to modulate 
behavioral and physiological abnormalities associated with neurodevelopmental disorders via 
circulating metabolites. Commensal bacteria were also shown to control the response of cancer 
to therapy by modulating the tumor microenvironment (148). This chapter discusses approaches 
for analyzing microbiome data, from the initial steps of processing raw sequencing data to the 
downstream analysis, including assessing community-level diversities and their association with 
outcomes of interest.  
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4.2 Methods in Human Microbiome Analysis 
 
4.2.1 Next-generation Sequencing Methods for the Human Microbiome 
 
Commonly used next-generation sequencing methods for analyzing the human microbiome 
include shotgun metagenomic sequencing and 16S ribosomal RNA (rRNA) sequencing (49)[49]. 
The shotgun metagenomic sequencing technique enables comprehensive sampling of all the 
genes over all organisms in a complex microbial sample; while the 16S rRNA sequencing 
approach focuses on identifying and comparing bacteria within a given sample (49)[49]. Over 
the last decade, 16S rRNA sequencing has become a popular technique to accurately identify 
bacterial isolates and discover novel bacteria in clinical studies of the microbiome (155). In 
particular, the 16S rRNA gene can be compared not only among all bacteria but also with the 
16S rRNA gene of archeobacteria and the 18S rRNA gene of eukaryotes (50). The 16S rRNA 
gene can be used as a stable phylogenetic marker to study the lineage relationships in the sample 
(156). The 16S rRNA gene has been identified for a large number of strains and is universal in 
bacteria. According to previous studies (50), identifying the bacteria isolated by a sequencing 
technique has the potential to better identify strains that are poorly described, rarely isolated or 
biochemically aberrant. The 16S rRNA sequencing technique can identify novel pathogens and 
lead to the discovery of noncultured bacteria (157, 158). Most importantly, although microbiome 
data can be generated using multiple methods, 16S rRNA sequencing is more efficient and less 
expensive compared to other methods and, thus, is still the most popular approach for generating 
such data (157, 158).  Therefore, we focus on data processing and analysis for microbiome data 
generated by the 16S rRNA sequencing approach. 
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4.2.1.1 Foregut Esophageal Adenocarcinoma Study 
 
We use the dataset from a study of esophageal adenocarcinoma in the foregut (159) to illustrate 
data analysis and interpretation for a microbiome study. That study sought to uncover the 
associations between esophageal adenocarcinoma risk and the composition of the microbiome. 
The project studied the microbiome at multiple stages of disease development, from normal to 
inflammation, metaplasia, and neoplasia, and also used invasive endoscopic procedures to 
sample the microbiome deep inside the human body. Esophageal adenocarcinoma is a rare but 
aggressive cancer that has been increasing in incidence, especially among white males. 
Esophageal adenocarcinoma develops in the distal esophagus in response to mucosal injury 
(159). Risk factors for esophageal adenocarcinoma include gastroesophageal reflux disease, 
cigarette smoking, obesity and low fruit or vegetable consumption, which together represent 
~80% of the population attributable risk. The characteristics of the esophageal microbiome may 
facilitate the development of disease (159). The study evaluated 104 individuals (16 females and 
88 males) and collected fecal and oral samples, as well as samples from the esophagus and 
stomach, for a total of 555 microbiome samples from different sites and different individuals. 
The sequencing data for all the microbiome samples were generated using the Roche 454 GS 
FLX Titanium platform (160) and Illumina HiSeq 2000 platform (161). For the purpose of the 
illustration, we randomly selected 40 oral samples, among which 20 samples were from healthy 
subjects and the other 20 samples were from the esophageal adenocarcinoma patients, for which 
the sequencing data were generated using the Roche 454 GS FLX Titanium platform.   
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4.2.1.2 Processing Raw Microbiome Sequencing Data 
 
Several pipelines are available to process raw microbiome data with millions of sequencing reads 
before assessing the association between microbial community profiles and outcomes of interest, 
among which the most popular pipelines are mothur (162) and Quantitative Insights into 
Microbial Ecology (QIIME, pronounced “chime”) (148, 162, 163). Mothur is an open-source, 
platform-independent, community-supported software that describes and compares microbiome 
communities (162).QIIME is a free and open-source analytic tool to process high-dimensional 
sequencing data (163). It has been shown that QIIME and mothur have similar statistical 
capabilities and user freedom; however, QIIME is more user-friendly than mothur as it is easier 
to understand and interpret the commands in QIIME than those in mothur (164). QIIME is 
available for analyzing whole metagenomic shotgun sequencing data, while mothur does not 
have this function (164). QIIME is preferred for analyzing large datasets due to the efficiency 
gain in computational time and the user-friendly interface. More importantly, the taxonomic 
summary table generated using QIIME is more easily adapted to the downstream analyses in 
statistical packages such as R (164). Therefore, in this study, we use QIIME to process the raw 
microbiome sequencing data and generate the operational taxonomic units (OTUs) for the 
downstream microbiome data analysis. QIIME can process raw sequencing data generated from 
different platforms, such as Illumina and 454 platforms (163).  
 
We describe the data processing procedure for data generated using the 454 platform. Typically 
the raw sequencing data are available in fasta and fastq formats. We review the commands for 
data processing, quality checking and OTU extraction based on these two data formats. In 
addition to the sequencing read files, a metadata mapping file is required for the purpose of data 
87 
 
processing. The metadata mapping file usually contains the following information: the name of 
each sample, barcode sequence for each sample, primer sequence used to amplify the sample, 
and a descriptive column (for example, health status, sampling site, or which medications a 
patient was taking at the time of sampling) (163). 
 
Figure 4 shows the basic procedure for processing the raw microbiome sequencing data. 
Specifically, we need to perform the steps described below, including demultiplexing, removing 
barcodes and primers and quality control checks, before generating OTUs for downstream 
analysis. The commands for processing the raw microbiome sequencing data and extracting the 
OTUs using QIIME are provided in the Methods section. 
 
(a) Demultiplexing: If multiple samples are pooled in one single lane by using the sample 
index or barcode adapters, then the step of demultiplexing is needed to divide one file of 
sequencing reads into separate files, where one file corresponds to one sample (163). 
 
(b) Removing barcodes: High-throughput sequencing allows multiple different independent 
samples to be sequenced during a single run. In this situation, each sample is tagged with 
a unique sequence that is referred to as a barcode. The QIIME software utilizes barcodes 
to demultiplex and assign sequences to each sample (165, 166). However, the barcodes 
incorporated in the sequencing reads need to be removed because the reads containing 
barcodes can lead to a mismatching issue in the downstream procedures (167).  
 
(c) Removing primers: The primer is a starting point for DNA synthesis, which consists of a 
short nucleic acid sequence. For living organisms, primers are short strands of RNA that 
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enzymes synthesize as a type of RNA polymerase before DNA replication occurs (168). 
It is a necessary step for the primer synthesis as DNA polymerases can only attach new 
DNA nucleotides to an existing strand of nucleotides (168). However, to avoid a 
mismatching issue when converting data into OTUs, it is necessary to remove the 
primers. We note that for some sequencing data downloaded from dbGaP, such as the 
data from the foregut esophageal adenocarcinoma study used here, the barcodes and 
primers have been removed before the investigators uploaded the data. In this situation, 
we do not need to conduct these two steps of removing barcodes and primers.  
 
(d) Quality filtering: The quality filtering step is used to remove any low-quality or 
ambiguous reads according to the quality scores provided in the sequencing. In the 454 
sequencing pipeline, the quality score assigned to each called base is the flowgram values 
rounded to the nearest integer in the Phred format. The Phred score is the probability that 
each nucleotide was incorrectly read (169). Based on the Phred score and a pre-specified 
threshold parameter, we can remove sequences that do not satisfy the desired quality 
(165).  
 
(e) Additional quality-control procedures: Sequencing platforms can produce characteristic 
sequencing errors, such as imprecise signals for longer homopolymer runs. The de-
noising procedure removes such errors and thereby improves the accuracy of the OTU 
generation. In addition, the raw sequencing data may contain chimeras generated by 
abnormal amplification during the process of polymerase chain reaction (PCR); these 
chimeras also need to be removed before generating OTUs.  
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Figure 4. Flowchart of basic steps in handling raw microbiome sequencing data 
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4.3 Diversity Measures of the Microbiome 
 
As stated previously, different species of microbes live as interacting communities, and the 
abundance and diversity of the microbiome is essential for maintaining human health (148). 
Measures of diversity, richness, and abundance are often used to summarize microbiome 
communities and compare them in different groups (148), among which the alpha (α) and beta 
(β) diversities are most commonly used. The alpha diversity measure shows the spatial patterns 
of biological diversity within a sample; thus, it evaluates the within-sample diversity (170). The 
beta diversity measure assesses the change in species composition between samples (170), 
evaluating the between-sample diversity. We describe several alpha and beta diversity measures 
commonly used in studies of the microbiome, with illustrations in the Methods section using the 
R package “phyloseq” (171), based on the data from the foregut esophageal adenocarcinoma 
study described previously.  
 
 
4.3.1 The 𝛂 Diversity of the Microbiome  
 
On the level of the microbial community, the clustering of OTUs allows us to measure the 
within-sample diversity (α diversity) of the microbiome. The observed richness, which is the 
simplest measure, refers to the number of species within a sample (172), but does not incorporate 
information about their relative abundance. Here, we introduce several commonly used measures 
for assessing 𝛼 diversity.  
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4.3.1.1 Shannon diversity index  
 
The Shannon diversity index is a popular measure of species diversity that measures the entropy 
and uncertainty of the sampling outcome (56). The Shannon diversity index is calculated as  
follows: Suppose 𝑛 is the total number of species, and pi is the proportion of species i relative to 
the total number of species in a community (173), then the Shannon diversity index is H =  −
∑ (pi× ln pi)
n
i=1 .  Higher values of the Shannon diversity index represent more diversity within a 
community; a value of 0 means the community has only one species. The Shannon diversity 
index is nonparametric, which allows for the simultaneous measurement of a richness estimation 
from heterogeneous samples (58) and takes into account both the relative abundance and total 
number of species in a microbiome community (173-175).  
 
 
4.3.1.2 Simpson’s diversity index 
 
The Shannon index emphasizes the richness component, while Simpson’s index stresses the 
evenness component (57). Simpson’s diversity index describes the probability that two randomly 
drawn reads from a sample are from the same taxon (56). Simpson’s diversity index is given as 
𝜆 = ∑ 𝑝𝑖
2𝑛
𝑖=1 , where 𝑛 is the total number of species, and pi is the proportion of species i relative 
to the total number of species in a community (173). Simpson’s diversity index is between 0 and 
1, where 0 represents infinite diversity and 1 implies no diversity. The higher the value of 
Simpson’s diversity index, the lower the diversity within the community.  
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For easier interpretation, the inverse Simpson’s diversity index, calculated as 1 𝜆⁄ , estimates the 
probability that two randomly chosen reads from a sample of the given community come from 
different taxa. A higher value for the inverse Simpson’s diversity index represents greater 
diversity. A previous study showed that Simpson’s diversity index has a small standard 
deviation, and for moderately large samples the bias is small (173). However, the inverse 
Simpson’s diversity index is biased when estimating numerous species that have low abundance 
within a community (56).   
 
 
4.3.1.3 Fisher’s 𝜶 diversity index 
 
Fisher’s 𝛼 diversity index describes the relationship between the number of species and the 
number of individuals of the corresponding species by logarithmic distribution. Compared with 
the Shannon index and Simpson’s index, Fisher’s 𝛼 diversity index is not influenced by the 
sample size and is less affected by the abundance of the most common species. Fisher’s 𝛼 index 
depends more on the number of species of intermediate abundance (174, 176).  
 
Fisher’s 𝛼 index is used to iteratively fit the logarithmic-series distribution (177, 178). According 
to Fisher’s theory, any population should have a constant value α for samples of any size taken 
from it under identical conditions (179). Suppose 𝑆 is the total number of species in the sample, 
and 𝑛 is the total number of individuals. The relative abundance is derived from the logarithmic-
series formed as 𝛼𝑥, 𝛼𝑥2 2⁄ , 𝛼𝑥3 3⁄ , … , 𝛼𝑥𝑛 𝑛⁄ , where the successive terms represent the 
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number of species predicted to have the corresponding 1, 2, 3, … , 𝑛 individuals. The parameter 𝑥 
is estimated by an iterative solution of 𝑆 𝑁⁄ = (1 − 𝑥) 𝑥(− ln(1 − 𝑥))⁄ , and the parameter 𝛼 is 
the log-series index of diversity. The two parameters 𝛼 and n summarize the distribution 
completely and are related by 𝑆 = 𝛼 ln(1 + 𝑛 𝛼⁄ ). The 𝛼 index can also be obtained by 𝛼 =
𝑛(1 − 𝑥) 𝑥⁄  (84, 178, 179). A higher value of Fisher’s 𝛼 index represents more diversity within 
the sample. The estimation of Fisher’s  𝛼 index gives an unbiased estimation of diversity (179). 
However, this approach is computationally intensive when the sample size is large.   
 
 
4.3.1.4 Chao1 𝜶 diversity index 
 
Because the abundance in microbiome OTU data is often low for many species, the Chao1 𝛼 
diversity index is defined as the number of species represented by just one or two individuals 
(58). The Chao1 𝛼 diversity index stresses the “singletons” (i.e., the number of species with only 
a single occurrence in the sample) and “doubletons” (i.e., the number of species with exactly two 
occurrences in the sample) and is calculated as follows: Suppose 𝑆𝑜𝑏𝑠 is the number of species 
for the sample, 𝐴1is the number of singletons, and 𝐴2is the number of doubletons, then 
𝐶ℎ𝑎𝑜1𝛼 = 𝑆𝑜𝑏𝑠 +
𝐴1
2
2𝐴2
2. A higher estimated value represents more diversity within the sample. 
The Chao1 𝛼 diversity index is particularly useful for microbiome datasets skewed to low 
abundance classes; while a drawback of the Chao1 𝛼 diversity index is that when the sample size 
is low, it underestimates the true value (180).   
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4.3.1.5 Abundance-based coverage estimator 
 
The abundance-based coverage estimator (ACE) (181, 182) measures the α diversity by 
separating the species into two groups: an abundant species group and a rare species group. 
Given a prespecified threshold 𝑘, the abundant species are those with more than 𝑘 taxa, and the 
rare species are those with less than or equal to 𝑘 taxa. A value of 𝑘 = 10 is suggested based on 
empirical evidence from previous studies (182, 183). The calculation of the ACE is described 
below (182). 
 
Given that 𝑓1 is the number of singleton species, 𝑓k is the number of species with exactly 𝑘 taxa, 
and 𝑆𝑜𝑏𝑠 is the total number of species in the sample, the number of rare species is described as 
𝑆𝑟𝑎𝑟𝑒 = ∑ 𝑓𝑘
10
𝑘=1 , and the number of abundant species is denoted as 𝑆𝑎𝑏𝑢𝑛𝑑 = ∑ 𝑓𝑘
𝑆𝑜𝑏𝑠
𝑘=11 , assuming 
the value of 10 is the threshold. The total number of taxa in the rare species is  𝑛𝑟𝑎𝑟𝑒 =
∑ 𝑘𝑓𝑘
10
𝑘=1 ,  and 𝐶𝐴𝐶𝐸 = 1 −
𝑓1
𝑛𝑟𝑎𝑟𝑒
 is the proportion of all non-singleton taxa in the rare species. 
Let  𝛾𝐴𝐶𝐸
2 = 𝑚𝑎𝑥 [
𝑆𝑟𝑎𝑟𝑒
𝐶𝐴𝐶𝐸
∑ 𝑘(𝑘−1)fk
10
𝑘=1
(𝑁𝑟𝑎𝑟𝑒)(𝑁𝑟𝑎𝑟𝑒−1)
− 1,0] be the coefficient of variation. The ACE of the 
species richness function is then 𝐴𝐶𝐸 = 𝑆𝑎𝑏𝑢𝑛 +
𝑆𝑟𝑎𝑟𝑒
𝐶𝐴𝐶𝐸
+
f1
𝐶𝐴𝐶𝐸
𝛾2𝐴𝐶𝐸 . A higher ACE value 
implies more diversity within the sample. The ACE takes into account both the abundant and 
rare species. However, the ACE underestimates the true richness at low sample sizes (180).  
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4.3.2 Microbiome 𝛃 Diversity  
 
The β diversity measure represents the species community composition between two or more 
samples. β diversity also refers to the turnover of the community composition from place to 
place or from time to time (184, 185). The species turnover is the change in species composition 
resulting from species extinction and immigration (186)[186]. Various metrics can be used to 
measure the  β diversity, such as the Manhattan index (187), Canberra index (188, 189), Jaccard 
distance (190), Kulczynski distance (190), binomial deviance (191), Morisita (192), Horn’s 
index (192),  Bray-Curtis (59), Cao dissimilarity index (60), and UniFrac (61).  
The Manhattan index is the sum of absolute value of difference in the corresponding taxa counts 
between two samples, which is simple to utilize, whereas it may be sensitive to outliers and the 
lack of information about relative abundance. (193) The Canberra index overcomes this 
limitation and uses the proportion of difference to estimate diversity. Canberra distance is a 
weighted version of Manhattan distance (194, 195). However, according to Emran & Ye(2002) 
(194), when noise level increases, the performance in Canberra distance may drop as it is 
sensitive to random error.  Another index is the Jaccard distance (196) measuring the 
dissimilarity between finite sample sets. Jaccard distance uses the size of the intersection divided 
by the size of the union of sample sets and measures the proportion of units not shared by the 
two observed samples. (197)  The Kulczynski distance gives both species the same influence and 
improve the dominance of common absences from Jaccard distance. However, there is a 
limitation in Kulczynski distance that if the two samples are very disparate in size and if all the 
elements on the smaller sample appear in the larger, then the minimum value of the coefficient is 
0.5 in which the coefficient’s value is very unsatisfactory. Anderson & Millar (2004) (198) 
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proposed binomial deviance as a dissimilarity measure for the abundance data based on 
likelihood theory. This measure assumes the null hypothesis that two samples do not differ in 
composition and relative abundance of species. That is, for each species, they expect that half of 
the counts will fall into each transect. (198) Thus, a useful measure of dissimilarity between two 
transects is the sum of these deviances across all species. To take account of the fact that 
different species may be varying on different scales, a scale-invariance measure may be obtained 
by considering this quantity on a per-observation basis. The null hypothesis for this metric is to 
check if the two compared communities are equal, which can be quantified by using the chi-
square test statistics. It should be able to handle variable sample sizes. The index does not have a 
fixed upper limit, but can vary among sites with no shared species. More details and discussions 
could be found in Anderson & Millar (2004) (198). Note that this binomial deviance 
dissimilarity is an improvement metric on the Bray-Curtis measure in terms of the likelihood 
theory. Here, the chi-square test statistic is equivalent to the dissimilarity measure known as the 
coefficient of divergence (Clark, 1952) (199). Hence, the binomial deviance has similar 
properties to the coefficient of divergence for use with species abundance data (198). Morisita 
proposed an index of similarity between communities. The Morisita metric is a statistical 
measure of dispersion of individuals in a population, and its extension (200) (Horn-Morisita 
variant) can be used to handle any abundance data. This is interpreted as the probability where 
two samples drawn randomly from two populations will belong to the same species, relative to 
the probability of randomly drawing two individuals of the same species alone (201). The 
Morisita’s measure is useful as an empirical measure though the probability interpretation is only 
rigorous when particular species counts are very large. Horn’s index is also an empirical 
measuring approach that utilizes different scaling factors based on Morisita metric. Horn index 
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improves from the Morisita’s index that the upper limit is exactly 1, which makes it easier to  
interpret (201). Horn’s index can also apply for clinical study and has been shown as a simple, 
useful, and aggregate scoring measure that enables combning disease severity and underlying 
comorbid conditions of the patient together (202). Specifically, we investigated the three widely 
used β diversity approaches in details, which are Bray-Curtis, Cao, and UniFrac.  
 
 
 
4.3.2.1 Bray-Curtis dissimilarity index 
 
The Bray-Curtis dissimilarity index measures the distance between two microbiome samples A 
and B by accounting for the abundance information (59). This approach does not require 
phylogenetic information. Given that nAj and nBj are the counts of the taxa in species j in samples 
A and B, and NA and NB are the total counts of all taxa in samples A and B, the Bray–Curtis 
dissimilarity index to measure the beta diversity between samples A and B is defined as (148) 
𝛽𝐵𝑟𝑎𝑦−𝐶𝑢𝑟𝑡𝑖𝑠 = ∑
|𝑛𝐴𝑗−𝑛𝐵𝑗|
(𝑁𝐴+𝑁𝐵)
𝑝
𝑗=1 , 
where p is the number of taxa in the samples. The Bray-Curtis index varies between 0 and 1. If 
the two microbiome samples A and B are identical in composition, then the index is 0 (i.e., 
coincidence). If there are no species in common between the two samples, then the index is 1 
(i.e., complementarity) (203).  
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One of the advantages of the Bray-Curtis index is the explicit meaning in the definition. The 
other advantage is the relative invariant characteristic that the relative values of a set of 
resemblances between two samples are not affected by a simple multiplicative scaling change 
(203). Also, the index is independent of joint absence, that is, the resemblance between two 
samples is not affected by the exclusion or inclusion of taxa that are absent (203). On the other 
hand, a common criticism of the Bray-Curtis index is its increasingly erratic behavior as values 
within samples become vanishingly sparse. When there are no taxa in both samples, the Bray-
Curtis index does not work because the denominator is zero. Furthermore, even if the taxa in the 
two samples are from different species, the two samples, which are not empty but nearly so, are 
considered similar when using the Bray-Curtis index (203).  
 
 
4.3.2.2 Cao dissimilarity index 
 
To overcome the shortcomings of the traditional measures for β diversity, such as the Bray-
Curtis index, Cao et al. (60) proposed a dissimilarity-similarity measure to respond to all of the 
types of variation with minimum bias in the weighting. The new dissimilarity measure, CY 
dissimilarity measure (CYd), is calculated as (60) 
𝐶𝑌𝑑 =  
1
𝑁
∑(
(𝑛𝐴𝑗 +𝑛𝐵𝑗) log10(
𝑛𝐴𝑗 +𝑛𝐵𝑗
2
)−𝑛𝐴𝑗  log10 𝑛𝐵𝑗−𝑛𝐵𝑗 log10 𝑛𝐴𝑗 
𝑛𝐴𝑗 +𝑛𝐵𝑗
), 
where 𝑛𝐴𝑗 is the counts of taxa for species 𝑗 in sample 𝐴; 𝑛𝐵𝑗 is the counts of taxa for species 𝑗 in 
sample 𝐵, and 𝑁 is the total number of species present in the two samples.  
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In this formula, the numerator summand (𝑛𝐴𝑗  + 𝑛𝐵𝑗) log10 (
𝑛𝐴𝑗 +𝑛𝐵𝑗
2
) − 𝑛𝐴𝑗  log10 𝑛𝐵𝑗 −
𝑛𝐵𝑗 log10 𝑛𝐴𝑗 is used to measure the dissimilarity between two samples. Caution should be taken 
when 𝑛𝐴𝑗 = 0 or 𝑛𝐵𝑗 = 0;  a small constant value (e.g., 0.1) can be assigned to  avoid a 
mathematical paradox. In this way, the measure can sensitively respond to all significant 
variations and weight them with minimum bias (60). The denominator 𝑛𝐴𝑗  + 𝑛𝐵𝑗 is used to 
eliminate the effect of absolute abundance of species. The 1/𝑁 term is used to yield an average 
value and reduces the effect from the monotonicity of the total dissimilarity measure with respect 
to the species number. If the Cao dissimilarity index is 0, then the two samples are identical 
overall. This metric ranges from 0 to ∞, with no fixed upper limit. A higher value of the Cao 
index means more dissimilarity between the samples. The Cao index (60) is considered to have a 
minimal bias in cases of high beta diversity and variable sampling intensity. This approach does 
not account for the phylogenetic information. 
 
 
4.3.2.3 Unique fraction measures 
 
The unique fraction (UniFrac) measures the difference between microbial samples by 
incorporating the phylogenetic information. The phylogenetic distance is measured between sets 
of taxa as the fraction of branch length in the phylogenetic tree that leads to descendants from 
either sample A or B, but not both (61). The UniFrac distance considers whether an OTU is 
present or absent in a sample but not the abundance information (204). To account for the 
corresponding phylogenetic information, we have a rooted phylogenetic tree for which 𝑛 is the 
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total number of branches, ℎ𝑘 is the length for branch k, and 𝑝𝐴𝑘 and 𝑝𝐵𝑘 are the taxa proportions 
descending from branch k for samples A and B, respectively. The unweighted UniFrac metric is 
then defined as (148)  
𝑑𝑈 = ∑
ℎ𝑘|𝐼(𝑝𝐴𝑘 > 0) − 𝐼(𝑝𝐵𝑘 > 0)|
∑ ℎ𝑘
𝑛
𝑘=1
𝑛
𝑘=1
 
where 𝐼(∙) is the indicator function that is used to indicate the presence or absence of a species 
from branch k with branch length ℎ𝑘.  
 
To account for the abundance information of taxa sets, a weighted UniFrac was proposed by 
weighting the branch lengths with differences in abundance as (148)  
𝑑𝑊 =
∑ ℎ𝑘|𝑝𝐴𝑘 − 𝑝𝐵𝑘|
𝑛
𝑘=1
∑ ℎ𝑘(𝑝𝐴𝑘 + 𝑝𝐵𝑘)
𝑛
𝑘=1
 
where 𝑝𝐴𝑘 and 𝑝𝐵𝑘 are the taxa proportions descending from branch k for samples A and B, 
respectively, and ℎ𝑘 is the branch length. The weighted UniFrac not only detects changes in the 
number of sequences present for each lineage, but also detects changes in which taxa are present 
(205). The weighted UniFrac can be normalized by the average distance for members in the two 
samples to the root, which corrects the unequal sampling effort or different evolutionary rates 
between taxa (204).  
 
The advantage of the Unifrac measure is that it can be used to compare multiple communities 
simultaneously, to determine whether there is a significant difference between communities. The 
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UniFrac measures, which utilize phylogenetic information, are more powerful than the other 
distance measures by exploiting the degree of divergence between different sequences (61). 
Also, the UniFrac measures are applicable for integrating sequencing data from multiple 
communities or studies, which makes it suitable for large-scale comparisons between 
environments. When the sample size is large, UniFrac measures can be robust to similar samples 
(61). The unweighted UniFrac has been shown to have superior power compared with the 
weighted UniFrac (206). A drawback is that the Unifrac measures can be computationally 
expensive. Meanwhile, the UniFrac measures do not account for the evenness component, so 
they cannot address how much of the observed community is attributable to the phylogenetic tree 
(61, 207).  
 
 
4.4 Association between Microbiome Diversity and Outcome  
 
After assessing the microbiome community measures, such as α and β diversities, interest may 
lie in evaluating the potential association between these measures and outcomes of interest. 
Specifically, to assess the impact of a difference in the α diversity on the outcome, the α 
diversity can simply be used as a covariate in a regression model, such as a linear or logistic 
regression model (148).  
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To assess the association between the β diversity and outcomes, the most commonly used 
approach is the permutation-based nonparametric multivariate analysis of variance using distance 
matrices (PERMANOVA) (208). PERMANOVA is a distribution-free test that measures the 
overall difference for multiple responses based on permutation tests and partitions a symmetric 
distance matrix based on linear models. The PERMANOVA approach cannot incorporate other 
covariates in the test, and may be confounded by dispersion effects (148, 208).  
 
 
4.4.1 Variable selection approach with sparse Dirichlet multinomial regression 
One can also estimate the associated covariates for taxa counts using Chen & Li (2013) (209) 
approach, which uses the variable selection approach with sparse Dirichlet multinomial 
regression to estimate the association between the microbiome composition and environmental 
covariates. This approach not only accounts for the overdispersion in taxa counts, but also 
overcomes the limitation of losing power in multiple testing when the number of covariates is 
large. The penalized likelihood approach imposes a sparse group 𝑙1 penalty to encourage both 
group level and within group sparsity. Given that there are 𝑞 bacteria taxa with corresponding 
counts 𝑌 = (𝑌1, 𝑌2, … , 𝑌𝑞) as random variables. Suppose the observed counts are 𝑦 =
(𝑦1, 𝑦2, … , 𝑦𝑞), and  𝑦+ = ∑ 𝑦𝑗
𝑞
𝑗=1 . The underlying species proportions are 𝜙 = (𝜙1, 𝜙2, … , 𝜙𝑞). 
The probability function is given as 𝑓𝑀(𝑦1, 𝑦2, … , 𝑦𝑞;  𝜙) = (
𝑦+
𝑦 ) ∏ 𝜙𝑗
𝑦𝑗𝑞
𝑗=1 . The counts 
marginally follow a Dirichlet-multinomial (DM) distribution as 𝑓𝐷𝑀(𝑦1, 𝑦2, … , 𝑦𝑞;  𝛾) =
(
𝑦+
𝑦 )
Γ (𝑦++1)Γ(𝛾+)
Γ(𝑦++𝛾+)
∏
Γ(𝑦𝑗+𝛾𝑗)
Γ(𝛾𝑗)Γ(𝑦𝑗+1)
𝑞
𝑗=1 , where 𝛾 = (𝛾1, 𝛾2, … , 𝛾𝑞) are positive parameters, and 𝛾+ =
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∑ 𝛾𝑗
𝑞
𝑗=1 . (209). To incorporate covariate effect vector 𝑋 = (𝑥1, 𝑥2, … , 𝑥𝑝), it is under the 
assumption that the parameters 𝛾𝑗 in the DM model depend on covariates through a log-linear 
model that 𝛾𝑗(𝑋) = exp(𝛼𝑗 + ∑ 𝛽𝑗𝑘𝑥𝑘
𝑝
𝑘=1 ), where 𝛽𝑗𝑘 is the coefficient effect on the 𝑗th taxon of 
the 𝑘th covariate. (45, 209) The penalty term of variable selection for sparse Dirichlet-
multinomial regression is 𝑝𝑙(𝛽; 𝑌, 𝑋, 𝜆1, 𝜆2) = −𝑙(𝛽; 𝑌, 𝑋) + 𝜆1 ∑ ||𝛽𝑘||2
𝑝
𝑘=1 + 𝜆2 ∑ ||𝛽𝑘||1
𝑝
𝑘=1 , 
where 𝑙(𝛽; 𝑌, 𝑋) is log-likelihood function, 𝜆1 and 𝜆2 are tuning parameters and ||𝛽𝑘||1 =
∑ |𝛽𝑖𝑘|
𝑞
𝑗=1  is the 𝑙1 norm, ||𝛽𝑘||2 = √
∑ 𝛽𝑖𝑘
2𝑞
𝑗=1  is the group 𝑙1 norm of coefficient vector 𝛽𝑘, 
respectively. (209) 
This approach has limitation that it does not incorporate phylogenetic information. One potential 
future research topic for extension of this approach is how to incorporate the phylogenetic tree 
information into the DM regression model for more accurately estimation (45).  
 
 
4.4.2 Microbiome Regression Based Kernel Association Test 
 
Zhao et al. (2015) (210) proposed the microbiome regression-based kernel association test 
(MiRKAT), which extend the association study that directly regresses the outcome on both 
covariate information and semi-parametric kernel machine regression. (210). Compared to 
PERMANOVA, MiRKAT is more computationally efficient and can adjust for other covariates 
when assessing the association between outcomes of interest and microbiome profiles.  
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The kernel in MiRKAT is capable of incorporating phylogenetic distance information, which 
enables easy covariate adjustment and extension to alternative outcomes including survival 
outcomes into MiRKAT modeling. This approach tests association through p-value by applying 
a variance component score statistic. MiRKAT provides fast computation and also regresses 
outcome on the whole microbiome pairwise similarity profiles. The framework of MiRKAT 
approach is as the following. (210) 
 
Suppose there are 𝑛 samples, and for the 𝑖𝑡ℎ subject, 𝑦𝑖 is the corresponding outcome. The 
abundances of all OTUs for individual 𝑖 is 𝒁𝑖 = (𝑍𝑖1, 𝑍𝑖2, … , 𝑍𝑖𝑝)
′
, where 𝑝 is the total number 
of OTUs. The covariate for individual 𝑖 is 𝑿𝑖 = (𝑋𝑖1, 𝑋𝑖2, … , 𝑋𝑖𝑚)
′. The goal is to test the 
association between outcome and microbial similarity profiles by adjusting covariates 𝑿. For 
continuous outcome variable, the linear kernel machine model is 𝑦𝑖 = 𝛽0 +  𝛽
′𝑿𝑖 + 𝑓(𝒁𝑖) + 𝜀𝑖; 
while for binary outcome variable, the logistic kernel machine model is logit( 𝑃(𝑦𝑖 = 1)) =
𝛽0 + 𝛽
′𝑿𝑖 + 𝑓(𝒁𝑖), where 𝛽0 is the intercept and 𝜷 = [𝛽1, 𝛽2, … , 𝛽𝑚]
′is the coefficients of 
covariates. 𝜀𝑖 is the error term with mean 0 and variance 𝜎
2 for continuous phenotypes. Under 
the kernel machine regression assumption, 𝑓(𝒁𝑖) is from a reproducing kernel Hilbert space, 𝐻𝑘, 
generated from a positive definite kernel function, 𝐾(. , . ), such that 𝑓(𝒁𝑖) = ∑ 𝛼𝑖′
𝑛
𝑖′=1 𝐾(𝑍𝑖, 𝑍𝑖′). 
Specifically, the kernel matrix can be constructed to be the transformation metrics of 
phylogenetic or taxonomic distance as 𝐊 = −
1
2
(𝐈 −
𝟏𝟏′
𝑛
)𝐃𝟐(𝐈 −
𝟏𝟏′
𝑛
), where 𝑫 = [𝑑𝑖𝑗] is the 
pairwise distance matrix such as Bray Curtis distance or weighted or unweighted UniFrac 
dissimilarity, 𝐈 is the identity matrix, 𝟏 is the vector of ones. The estimation of coefficients 𝛽 and 
𝑓(𝒁) is to maximize the penalized log-likelihood of 𝑝𝑙(𝑓, 𝛽) = ∑ log 𝐿(𝑓, 𝛽; 𝑦𝑖, 𝑥𝑖 , 𝑧𝑖) −
1
2
𝜆 ∥𝑛𝑖=1
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𝑓 ∥𝐻𝑘
2 = ∑ log 𝐿(𝑓, 𝛽; 𝑦𝑖 , 𝑥𝑖, 𝑧𝑖) −
1
2
𝜆𝛼′𝐾𝛼𝑛𝑖=1 . In order to test the association between outcome 
and microbiome profiles, MiRKAT approach uses variance component score test. The score 
statistic is 𝑄 =
1
2𝜙
(𝒚 − 𝒚0̂)
′𝑲(𝒚 − 𝒚0̂), where 𝑦0̂ is the predicted mean of y under null 
hypothesis that there is no association between microbiome profiles and outcome as 𝑓(𝒁) = 0. 𝜙 
is the dispersion parameter, where 𝜙 = 𝜎0̂
2
 and 𝜎0̂
2
 is the estimated residual variance under null 
hypothesis for linear kernel machine regression, and 𝜙 = 1 for logistic kernel machine 
regression. (210) 
An essential advantage of the score test is that it only requires fitting null model and allows for 
fast, supervised, distance-based association testing under regression framework which permits 
controls for potential confounding effect. Better kernels chosen improves statistical power. Even 
if a poor kernel is chosen, the test is still statistically valid. Another advantage of MiRKAT 
enables to simultaneously consider multiple distance and dissimilarity metrics. An alternative 
approach for the MiRKAT is to implement a weighted combination of multiple kernels.  
This approach can be implemented using the R package “MiRKAT.”  (210) 
 
 
4.5 Challenges in Analyzing Microbiome Data 
 
This chapter covers relatively basic strategies for analyzing microbiome data, with the use of the 
community-level summary measures (e.g., α and β diversities). However, analyzing microbiome 
data can be challenging. First, there are challenges in data normalization and taxonomic 
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abundance estimation (148). For a single sample with high-throughput sequencing reads, the big 
data also present challenges for correct and full assembly and effective computing (69). 
Moreover, there are challenges to analyzing microbiome data. In particular, the relative 
abundances of species for one sample are usually quantified as a vector of the compositional 
data, which is calculated by dividing the observed count in the taxa or OTUs by the total reads in 
the sample, resulting in a vector of proportions residing in a nonnegative simplex. It is not 
straightforward to model the joint distribution of such data. The Dirichlet class of distributions is 
the most commonly used distribution to model such data (148, 211, 212). Alternatively, the 
compositional data can be transformed before conducting the analysis, which may include using 
square root transformation, additive log-ratio transformation or centered log-ratio transformation 
(148, 213). Shi et al. (214) presented linear regression models for compositional microbiome 
data analysis, using  a set of linear constraints on the regression coefficients and estimating the 
regression coefficients by using a penalized estimation procedure.  
 
However, these methods might not be able to address the complexity of microbiome data, 
especially the sparsity of the compositional data that involves a large number of zeros, because 
most OTUs have extremely low abundance and a large proportion of OTUs occur only once 
(possibly resulting from sequencing error) (148). Such a sparsity property increases the difficulty 
in analyzing the composition of the microbiome. For example, the commonly used statistical 
approaches, such as regression models and correlation measures, might not be directly applicable 
to such data. Moreover, the compositional data of the microbiome are intrinsically high 
dimensional, which further compounds the challenge for analyzing such data.  
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This chapter does not cover the analysis of longitudinal microbiome data, which are commonly 
observed in current studies of the human microbiome. Compared to cross-sectional analysis, 
longitudinal data analysis allows the relative abundances for a single individual to vary over time 
and utilizes dynamic modeling to understand the dependencies between species (214). Such 
longitudinal data are important when assessing microbial changes throughout treatment (e.g., 
during chemotherapy) and the impact of such changes on long-term outcomes of interest (e.g. 
overall survivorship). There are challenges and obstacles for such analyses (214): (i) the 
correlation between the abundances of species does not imply that these species directly interact, 
(ii) the constraint on the sum of relative abundance makes it difficult to perform parameter 
inference in longitudinal models, and (iii) errors due to experimental uncertainty or biased 
inferences of the interaction of species may occur for the longitudinal model. Fisher & Mehta 
(214) proposed the approach of learning interactions from microbial time series (LIMITS) for 
analyzing longitudinal microbiome data. The LIMITS approach uses a sparse linear regression 
method with boostrap aggregation to infer the discrete time Lotka-Volterra model for microbial 
dynamics, which allows this approach to overcome the three aforementioned obstacles (214). 
Alternative methods for analyzing longitudinal microbiome data include using a Bayesian 
network (215) and a two-part mixed effects model (216). 
 
In the next section, we provide commands for processing the raw microbiome sequencing data 
and extracting the OTUs, and demonstrate how to assess alpha diversities, beta diversities, and 
evaluate the association between diversities and outcomes of interest using a regression model, 
PERMANOVA and MiRKAT, based on the data from the foregut esophageal adenocarcinoma 
study described previously.  
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4.6. Processing Methods and Results 
 
We provided commands in QIIME (163) for processing raw microbiome sequencing data and 
generating an OTU table. We used the “phyloseq” package in the R program (171) to assess the 
α and β diversities, the “vegan” package in R to conduct the PERMANOVA test, and 
“MiRKAT” package in R to conduct the MiRKAT test (217).  
 
4.6.1 Processes to Convert Raw Data into the OTU Table 
 
 
4.6.1.1 Demultiplexing data  
 
1. For data in fasta format 
 
The command demultiplex_fasta.py can demultiplex sequences from one input fasta file by using 
barcodes and/or data from the fasta labels provided in a metadata mapping file. Note that the 
information for the barcode is necessary for the purpose of demultiplexing.   
Input data files: (1) read.fasta file, (2) metadata mapping file 
Output files: directory of output files, including seqs.fna, demultiplexed_sequences.log, 
seqs.qual, and seqs_not_assigned.fna 
 
demultiplex_fasta.py –f [read.fasta file] –m [metadata mapping file] –o [output directory 
name] 
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2. For data in fastq format 
 
The function of split_libraries_fastq.py can demultiplex sequences from a data file in the fastq 
format in which the barcodes and sequences are stored in two separate fastq files (163). 
 
Input data files: (1) read.fastq file, (2) barcode fastq file 
Output files: directory of output files, including seqs.fna, split_libraries_log.txt, histograms.txt   
 
split_libraries_fastq.py –i [read.fastq file] –b [barcode fastq file] –o [output directory name] 
 
 
4.6.1.2 Removing barcodes  
 
1. The barcodes can be removed when demultiplexing is conducted. Specifically, for the files in 
the fasta format, demultiplex_fasta.py removes the barcodes for the output sequences as a 
default.  
2. For data in the fastq format, the barcode extraction command can be used to remove barcodes.  
 
Input files: read.fastq file 
Output files: directory of output files 
 
extract_barcodes.py –f [read.fastq file] –c [input type of barcode] –-bc1_len [barcode length]–o 
[output directory name] 
110 
 
 
4.6.1.3 Removing primers 
 
1. The primers can be removed by using a Perl script if the primers are known. This can be used 
for data in both fasta and fastq formats.  
 
Input files: read file  
Output files: new file with primer removed 
 
use strict; 
use warnings; 
use Cwd; 
my @fw_primers = ("AGAGTTTGATCCTGGCTCAG",  "TACGGRAGGCAGCAG",        
"GCCAGCAGCCGCGGTAA", "AGGATTAGATACCCT", "GAATTGACGGGGRCCC", 
"GYAACGAGCGCAACCC"); 
my $dir = getcwd; 
opendir(DIR, $dir) or die $!; 
while (my $file = readdir(DIR)) { 
    next if ($file =~ m/^\_/); 
 next if ($file =~ m/^\./); 
 print $file; 
 open(IN, $file) or die $!; 
 my $outfile = "_dePrimer_".$file; 
 open(OUT,">$outfile"); 
 while(my $line = <IN>){ 
  foreach my $aprimer (@fw_primers){ 
   $line =~s/$aprimer/\#/g;} 
  $line =~s/\#//g; 
  print OUT $line; } 
 close(OUT); 
 close(IN);} 
closedir(DIR); 
exit 0; 
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2. The barcode extraction command can be used twice to remove both the barcode and primer 
(163). 
 
Input files: read.fastq file, metadata file 
Output files: directory of output files, including barcode file and read file(s) 
 
extract_barcodes.py –f [read file] –m [metadata file] –o [output directory name] 
 
 
 
4.6.1.4 Performing quality filtering  
 
1. For data in fastq format 
 
Quality filtering in QIIME is performed as part of split_libraries_fastq.py (see Note 1). The 
following command can be executed to combine all the fastq files into one. 
 
 
Input files: (1) directory of multiple fastq read files (2) parameter file 
Output files: directory of output files, including seqs.fna file, which are used to select OTUs  
multiple_split_libraries_fastq.py -i [input directory] -p [file path or name of parameter file] -o 
[output directory]  
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2. For data in fasta format 
 
Quality filtering can be conducted by following the three steps described below. 
 
Step 1: Clean the data to remove the incompatible lines and make the file compatible with 
QIIME (Note 2).  
 
Input files: fasta read file(s) 
Output files: directory of output fasta files 
 
clean_fasta.py –f [read file name] –o [output file directory] 
Step 2: Use split_metadata.py and split_library.py to transform from the previous combined fasta 
file format  into another fasta format by parsing the sequences that meet user-defined quality 
thresholds and then renaming each read with the appropriate sample ID (163, 218).  
 
 
Step 3: Concatenate all the fasta files using cat in linux. 
 
Input files: multiple fasta read files 
Output files: fasta file (.fna format) 
 
cat file1 file2 … file N > seq.fna 
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4.6.1.5 Additional quality control procedures  
 
As described above, additional quality control procedures may be conducted. For example, the 
functions of split_libraries.py and denoise_wrapper.py can be used to de-noise the data (163). 
Also, if chimeras are present in the sequencing read files, the function 
parallel_identify_chimeric_seqs.py can be used to identify chimeric sequences and apply the 
function of filter_fasta.py to filter the chimeras from the files (163). 
 
 
 
4.6.1.6 Select OTUs 
 
There are three approaches for picking OTU tables in QIIME. The first one is de novo OTU 
picking, which clusters reads against one another based on the similarity between reads (e.g., 
default is 97%) without utilizing sequencing information from external references (163). A 
drawback to the de novo approach is that there is no existing support for parallel computing in 
QIIME, which may slow down the process (163).  
 
Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file) 
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted 
OTU table 
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pick_de_novo_otus.py –i [input read file] –o [output directory name] 
 
The second approach for selecting the OTU is closed-reference OTU picking, where reads are 
clustered against a reference. The reads that do not map to the reference are excluded from the 
downstream analysis. The reference database used by default in QIIME is constructed by 
clustering the full-length 16S rRNA sequences with 97% similarity in sequence fragments from 
the Greengenes database (55, 219, 220). The drawback of this closed-reference approach is that, 
by discarding reads that do not match the reference, the ability to detect novel diversity is lost 
(163). 
 
Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file) 
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted 
OTU table 
 
pick_closed_reference_otus.py –i [input read file] –o [output directory name] 
The third approach is the open-reference OTU picking approach. It combines the de novo and 
closed-reference OTU picking approaches. The reads are first clustered against a reference, and 
any reads that do not match the reference are clustered according to the de novo approach. All 
reads in the sample are clustered by the open-reference approach (163). For illustration, we used 
the open-reference OTU picking approach for the foregut esophageal adenocarcinoma dataset. 
 
Input files: fasta file (seqs.fna, which is a post-split_libraries fasta file) 
Output files: directory of output files, including a phylogenetic tree file and a biom-formatted 
OTU table 
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pick_open_reference_otus.py –i [input read file] –o [output directory name] 
4.6.1.7 Summary of the OTU table 
 
After selecting the OTU, we can summarize the generated OTU table in terms of the number of 
samples, the number of observations and a summary of the total counts observed for each sample 
(163). The OTU picking procedure may exclude some samples with low-quality scores in the 
OTU table file.  
 
Input files: the file generated in the previous OTU picking step, called 
“otu_table_mc2_w_tax_no_pynast_failures.biom” 
Output files: summary of OTU picking result 
biom summarize-table -i otu_table_mc2_w_tax_no_pynast_failures.biom 
 
 
4.6.2 Import OTUs into R for Downstream Analysis 
 
There are multiple ways to import the OTUs generated by QIIME into R (221) for the 
downstream analysis, as described below.  
 
 
4.6.2.1 Read .biom file into R by using “compositional” library and QIIME  
 
1. Convert .biom format to .txt file in QIIME (163).  
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Input files: biom format file 
Output files: file in the tab-delimited table format  
 
biom convert -i otu_table_mc2_w_tax_no_pynast_failures.biom -o 
table.from_biom_w_taxonomy_2.txt --to-tsv 
 
 
 
 
 
2. Use R library to read the .txt file and convert to OTUs (222). 
 
Input files: file in the tab-delimited table format from previous biom conversion step 
Output files: OTU object of compositions in the framework of Aitchison Simplex by acomp( ) or 
compositions as elements of simplex embedded in D-dimensional real space by rcomp( ) 
 
install.packages("compositions") 
library(compositions) 
 
sample<-read.table("table.from_biom_w_taxonomy_2.txt ")  
counts_sample<-sample[,-1] 
t_ct_sample<-t(counts_sample) 
closure_t_sample<-clo(t_ct_sample) 
comp_sample<-acomp(closure_t_sample)  
 
or  
 
real_sample<-rcomp(closure_t_sample)  
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4.6.2.2 Read .biom file and phylogenetic tree information into R using the “phyloseq” 
package (171) 
 
1. Install “phyloseq” package 
source("https://bioconductor.org/biocLite.R") 
biocLite("phyloseq") 
 
or 
 
install.packages("devtools") 
library("devtools") 
install_github("phyloseq", "joey711") 
library("phyloseq") 
 
 
2. Import .biom file  
 
Input files: (1) biom file (2) tree file 
Output files: OTU object 
 
biom_sample<-import_biom("otu_table_mc2_w_tax_no_pynast_failures.biom", 
treefilename="rep_set.tre") 
otu_sample<-otu_table(biom_sample) 
 
3. Import phylogenetic tree file into R 
 
Input files: tree file in  
Output files: phylo class object  
 
tree_sample<-read_tree("rep_set.tre") 
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4.6.3 Computations of the Diversities 
 
For the calculations of the diversities, the input object “biom_sample”, which is necessary for all 
scripts presented below, is obtained using the import_biom command in the “phyloseq” package 
described previously. 
 
4.6.3.1 Alpha Diversity 
## summarize alpha diversity  
> alpha_biom_sample<-estimate_richness(biom_sample,measures=c("Observed", "Chao1", "ACE", 
"Shannon", "Simpson", "InvSimpson", "Fisher"))  
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Table 15. Alpha diversity for foregut esophageal adenocarcinoma dataset  
 
 
  
Observed 
richness 
Chao1 ACE Shannon Simpson InvSimpson Fisher 
SRR1023240 818 1167.20 1300.73 5.05 0.98 50.09 250.41 
SRR1023425 904 989.52 1084.98 3.73 0.94 16.51 190.43 
SRR1023460 1144 1468.38 1615.59 3.59 0.89 8.87 244.86 
…               
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Table 15 reports α diversities for microbiome samples from the foregut esophageal 
adenocarcinoma study using various alpha diversity measures. In Table 15, we denote the 
Shannon diversity index as Shannon, Simpson’s index as Simpson, inverse Simpson’s diversity 
index as InvSimpson, Fisher’s 𝛼 diversity index as Fisher, Chao1 𝛼 diversity index as Chao1, 
and the abundance-based coverage estimator as ACE. The observed richness measure, Chao1 
measure, and the ACE measure are generally higher than the Shannon index, InvSimpson, and 
Fisher’s alpha index. For example, the α diversity for sample SRR1023425 is 904 using the 
observed richness, 989.52 using the Chao1 index, and 1084.98 in the ACE measure, respectively; 
while the α diversities are respectively 3.73, 16.51, and 190.43 when using the Shannon, 
InvSimpson, and Fisher diversity measures. The different 𝛼 diversity measures assess different 
aspects of the community. For instance, a Shannon index implies higher uncertainty in correctly 
predicting the identity of the next species chosen at random for the given sample (175) . 
Simpson’s index emphasizes the evenness component in the sample (57). For example, for 
sample SRR1023240, Simpson’s index is 0.98, which means that within the sample, the 
probability that two randomly selected taxa belong to the same species is as high as 0.98. We 
used the coefficient of variation to compare the different alpha diversity measures (see Note 3).   
 
4.6.3.2 Plot Richness Graph 
> ## plot alpha diversity 
> plot_richness(biom_sample, measures=c("Observed", "Chao1", "ACE", "Shannon", "Simpson", 
"InvSimpson", "Fisher")) 
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Figure 5. Alpha diversity plots for the foregut esophageal adenocarcinoma dataset 
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Figure 5 shows the richness of each sample using different alpha diversity measures, including 
the observed richness, Chao1, ACE, Shannon, Simpson’s, inverse Simpson’s, and Fisher index. 
The alpha diversity is relatively more evenly distributed when using the observed richness, 
Chao1, and Shannon index compared to those obtained using inverse Simpson’s and Simpson’s 
index.  
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2 Beta Diversity 
 
4.6.3.2.1 Bray-Curtis Dissimilarity Index   
> bray_dist <- distance(biom_sample, "bray") 
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Table 16. Bray-Curtis dissimilarity index using the foregut esophageal adenocarcinoma 
dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 0.81     
SRR1023263 0.81 0.83    
SRR1023425 0.89 0.91 0.72   
SRR1023460 0.89 0.88 0.79 0.68  
SRR1023343 0.82 0.86 0.88 0.91 0.91 
…           
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Table 16 shows the Bray-Curtis dissimilarity index for the foregut esophageal adenocarcinoma 
dataset. The larger the difference between two samples, the larger is the Bray-Curtis dissimilarity 
index. From Table 16, we observe that the difference between samples is relatively high, 
generally greater than 0.5. For example, the Bray-Curtis dissimilarity index between samples 
SRR1023425 and SRR1023582 is 0.91. The Bray-Curtis dissimilarity index between samples 
SRR1023425 and SRR1023263 is 0.72. Thus, sample SRR1023425 is more similar to sample 
SRR1023263 compared with sample SRR1023582. 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2.2 Cao Dissimilarity Index 
> cao_dist <- distance(biom_sample, "cao") 
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Table 17. Cao dissimilarity index using the foregut esophageal adenocarcinoma dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 2.28     
SRR1023263 2.26 2.41    
SRR1023425 2.31 2.45 2.34   
SRR1023460 2.21 2.35 2.28 2.33  
SRR1023343 2.17 2.34 2.35 2.34 2.28 
…           
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Table 17 shows the Cao dissimilarity index for the foregut esophageal adenocarcinoma dataset. 
A higher Cao dissimilarity index indicates more dissimilarity between samples. For example, the 
index between samples SRR1023582 and SRR1023425 is 2.45, while the index between samples 
SRR1023582 and SRR1023460 is 2.35, which implies that samples SRR1023460 and 
SRR1023582 are more similar compared with samples SRR1023425 and SRR1023582. 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2.3 UniFrac Measures 
 
4.6.3.2.3.1 Unweighted UniFrac measure 
> unweighted_unifrac<-distance(biom_sample,"uunifrac") 
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Table 18. Unweighted UniFrac measure for the foregut esophageal adenocarcinoma dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 0.80     
SRR1023263 0.82 0.83    
SRR1023425 0.86 0.88 0.79   
SRR1023460 0.82 0.85 0.81 0.83  
SRR1023343 0.78 0.79 0.83 0.85 0.84 
…           
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Table 18 lists the results of the unweighted UniFrac measure for the foregut esophageal 
adenocarcinoma dataset. A higher value of the UniFrac measure indicates more dissimilarity 
between the samples. For example, the unweighted UniFrac dissimilarity between samples 
SRR1023240 and SRR1023582 is 0.80. The dissimilarity between SRR1023460 and 
SRR1023240 is 0.82, which implies that sample SRR1023240 is more similar to sample 
SRR1023460 compared with sample SRR1023582.  
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2.3.2 Weighted UniFrac measure 
> weighted_unifrac<-distance(biom_sample,"wunifrac") 
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Table 19. Weighted UniFrac measure for the foregut esophageal adenocarcinoma dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 0.37     
SRR1023263 0.41 0.44    
SRR1023425 0.54 0.58 0.43   
SRR1023460 0.50 0.51 0.47 0.41  
SRR1023343 0.41 0.35 0.38 0.42 0.42 
…           
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The dissimilarity values in Table 19 are lower overall than those in Table 18, which were 
obtained using the unweighted UniFrac measure. Nonetheless, the patterns are similar. For 
example, in Table 19, the weighted UniFrac dissimilarity between sample SRR1023240 and 
sample SRR1023582 is 0.37, and the weighted UniFrac dissimilarity between sample 
SRR1023263 and SRR1023240 is 0.41.  
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2.3.3 Normalized unweighted UniFrac measure 
> unweighted_unif_norm<-UniFrac(biom_sample, weighted=FALSE, normalized=TRUE) 
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Table 20. Normalized unweighted UniFrac measure for the foregut esophageal 
adenocarcinoma dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 0.80     
SRR1023263 0.82 0.83    
SRR1023425 0.86 0.88 0.79   
SRR1023460 0.82 0.85 0.81 0.83  
SRR1023343 0.78 0.79 0.83 0.85 0.84 
…           
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Table 20 shows the results for the normalized unweighted UniFrac dissimilarity, which is 0.82 
between sample SRR1023460and sample SRR1023240, and 0.80 between sample SRR1023240 
and sample SRR1023582.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6.3.2.3.4 Normalized weighted UniFrac measure 
> weighted_unif_norm<-UniFrac(biom_sample, weighted=TRUE, normalized=TRUE) 
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Table 21. Normalized weighted UniFrac measure for the foregut esophageal 
adenocarcinoma dataset  
 
 
  SRR1023240 SRR1023582 SRR1023263 SRR1023425 SRR1023460 
SRR1023582 0.34     
SRR1023263 0.36 0.38    
SRR1023425 0.42 0.44 0.31   
SRR1023460 0.40 0.41 0.36 0.27  
SRR1023343 0.34 0.29 0.30 0.29 0.30 
…           
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Table 21 provides the results of the normalized weighted UniFrac measure for the foregut 
esophageal adenocarcinoma dataset. The distance between samples SRR1023263and 
SRR1023240 is 0.36. The distance between samples SRR1023263 and SRR1023582 is 0.38, 
which implies that sample SRR1023263 is more similar to sample SRR1023240 compared with 
sample SRR1023582.  
 
 
 
4.6.4 Association Tests 
 
 
4.6.4.1 Regression Models for Alpha Diversity 
 
>sample_data<-read.table("book_chapter_samples_2.txt") 
>colnames(sample_data)<c("Run","disease_affected_status","Sex","BioSample","sample_name","SR
A_sample","dbGap_sample_id") 
>sample_sex<-(sample_data$Sex == "male")**2 
>disease_status<-(sample_data$disease_affected_status== "Yes")**2 
>alpha_biom_sample<-estimate_richness(biom_sample,measures=c("Observed", "Chao1", "ACE", 
"Shannon", "Simpson", "InvSimpson", "Fisher")) 
>fit<-glm(disease_status~alpha_biom_sample$Chao1,family="binomial")  
>summary(fit) 
 
 
To study the association between outcomes and α diversity, we applied logistic regression for 
each of the α diversity measures using the foregut esophageal adenocarcinoma dataset. We used 
the esophageal adenocarcinoma status as the outcome variable. The input information is 
available in the file book_chapter_samples_2.txt. The association results show that the P-value is 
0.18 for the observed richness approach, 0.33 for the Chao1 index, 0.33 for the ACE approach, 
135 
 
0.36 for the Shannon index, 0.98 for Simpson’s index, 0.97 for the inverse Simpson’s index, and 
0.52 for the Fisher index approach. Therefore, at the nominal significance level of 0.05, there is 
no association between esophageal adenocarcinoma status and α diversity.  
 
 
4.6.4.2 Permutation-based Nonparametric MANOVA (PERMANOVA) 
 
The PERMANOVA test can be applied by using R package “vegan” (223)as described here. 
Similar to the association test for alpha diversity, we used the esophageal adenocarcinoma status 
as the outcome variable. We used the Bray-Curtis measure as the dissimilarity metric for the 
illustration below. Other beta diversity measures can also be used by modifying the argument in 
the “distance” function.  
 
>sample_data<-read.table("book_chapter_samples_2.txt") 
>colnames(sample_data)<-
c("Run","disease_affected_status","Sex","BioSample","sample_name","SRA_sample","dbGap_sample_
id") 
>sample_sex<-(sample_data$Sex == "male")**2 
>disease_status<-(sample_data$disease_affected_status== "Yes")**2 
>bray_dist <- distance(biom_sample, "bray") 
>adonis(bray_dist~disease_status ) 
 
 
Given 20 oral samples from healthy subjects and 20 oral samples from the patients with 
esophageal adenocarcinoma, the PERMANOVA test gives a P-value of 0.15 for the association 
between esophageal adenocarcinoma status and the Bray-Curtis dissimilarity measure. The P-
values for the other beta diversity measures were 0.07 for Cao beta diversity, and 0.17 and 0.04 
for the unweighted and weighted UniFrac measures, respectively. 
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4.6.4.3 Microbiome Regression-based Kernel Association Test (MiRKAT) 
 
The R packages of “MiRKAT” (217), “phyloseq” (171), and “ape” (224)are needed to perform 
the MiRKAT test. In addition to the information about OTUs 
(otu_table_mc2_w_tax_no_pynast_failures.biom), to conduct this test, information is needed on 
the phylogenetic tree (rep_set.tre file) and phenotypes (book_chapter_samples_2.txt file). Given 
all these files, the MiRKAT test, using the UniFrac measure in the kernel matrix, can be 
conducted by running the following script:    
 
>##import biom file into phyloseq library 
>biom_sample<-import_biom("otu_table_mc2_w_tax_no_pynast_failures.biom", 
treefilename="rep_set.tre") 
>otu_sample<-otu_table(biom_sample) 
>### read tree file  
>tree_sample<-read_tree("rep_set.tre") 
>##Prepare the data 
>sample_data<-read.table("book_chapter_samples_2.txt") 
>colnames(sample_data)<c("Run","disease_affected_status","Sex","BioSample","sample_name","SR
A_sample","dbGap_sample_id") 
>sample_sex<-(sample_data$Sex == "male")**2 
>disease_status<-(sample_data$disease_affected_status== "Yes")**2 
>#transpose otu sample 
>trans_otu_sample<-t(otu_sample) 
>#root the tree 
>tr <- root(tree_sample,1,resolve.root=TRUE) 
>#Create the UniFrac Distances 
>otu.tab.rff <- Rarefy(trans_otu_sample)$otu.tab.rff 
>unifracs <- GUniFrac(otu.tab.rff, tr, alpha=c(0, 0.5, 1))$unifracs 
>D.weighted = unifracs[,,"d_1"] 
>D.BC= as.matrix(vegdist(otu.tab.rff , method="bray")) 
># Convert Distances to kernel matrices 
>K.weighted = D2K(D.weighted) 
>K.BC = D2K(D.BC) 
># Testing using a single kernel 
>MiRKAT(y = disease_status, Ks = K.weighted, X = sample_sex,out_type = "D",method = 
"permutation", nperm=10000) 
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Given 20 oral samples from healthy subjects and 20 samples from the patients with esophageal 
adenocarcinoma, the MiRKAT test gives a P-value of 0.04. The MiRKAT test accounts for the 
covariates, which may have confounding effects, and incorporates the phylogenetic tree 
information; therefore, the MiRKAT approach can be robust compared to the PERMANOVA 
approach.  
 
 
4.7. Notes 
 
1. Details on the quality filtering strategy in QIIME, including motivation for the default 
parameter settings, are provided by Bokulich et al. (225). We note that the threshold parameter 
may require modification for quality scores, if necessary, by the creation of a parameter file. For 
example, the threshold parameter can be defined as given below in the parameter file. 
 
split_libraries_fastq:phred_offset 33 
 
2. It needs to install the PrimerProspector, a pipeline of programs for designing and analyzing 
PCR primers (226), to make the file compatible with QIIME. 
 
3. To compare the different alpha diversity measures, we calculated the coefficient of variation, 
which is the ratio of the standard deviation to the mean, for each of the measures using the 
foregut esophageal adenocarcinoma dataset. The coefficient of variation shows the variability of 
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each measure over all the samples. The results show that the variability is 0.43 for the observed 
approach, 0.43 for the Chao1 index, 0.43 for the ACE approach, 0.2 for the Shannon index, 0.1 
for Simpson’s index, 0.82 for inverse Simpson’s index, and 0.41 for the Fisher index approach. 
Among all the approaches, the inverse Simpson’s index has the highest variability, while the 
Shannon index and Simpson’s index have relatively lower variability. Based on the coefficient of 
variation, the Shannon index and Simpson’s index have less variability than the other measures.  
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Chapter 5 
Conclusions and Future Directions 
 
 
This chapter summarizes the thesis, discusses its findings and contributions, points out 
limitations of the current work, and also outlines directions for future research. Depending on the 
genomic data for the human and microbiome, the aim of this thesis is to explore the statistical 
applications of frequentist methods to the sequencing data. However, many extensions of this 
research deserve further consideration under the Bayesian statistical point of view. The chapter is 
divided into two sections. Section 5.1 summarizes the thesis and provides conclusions. Section 
5.2 discusses future work. 
 
 
  
140 
 
5.1 Conclusions 
 
 
In this dissertation, we investigated and developed novel statistical approaches for assessing 
human and microbiome genetic data. First, we introduced the definition of sequencing data and 
summarized the well-known sequencing techniques and approaches, e.g., Sanger sequencing, 
next-generation sequencing, DNA sequencing, and RNA sequencing approaches. Detailed 
discussions were provided as the background of our proposed methods. We also gave a brief 
introduction to the definitions of 16S rRNA and provided background information for the human 
microbiome, which may be associated with human disease.  
In Chapter 2, we introduced the sequencing error rates in next-generation sequencing short read 
data and reviewed the traditional error rate estimation approaches, including the shadow 
regression estimation method. When estimating sequencing error rates, the shadow regression 
estimation approach is widely used, but operates under the linearity assumption that the number 
of shadow counts increases linearly with the number of error-free read counts, which may not be 
appropriate for all types of sequencing data. To obtain a unified model, we developed the 
empirical error rate estimation approach by using a nonlinear statistical model of cubic 
smoothing splines or robust smoothing splines to estimate the shadow counts in next-generation 
sequencing data. Our proposed empirical error rate estimation approach is applicable for multiple 
datasets, including DNA sequencing data and mRNA sequencing data. Under all the simulation 
scenarios tested, our proposed empirical error rate estimation approach is less biased than 
shadow regression estimation. We also reproduced the results of the Wang et al. simulation study 
(4). We note that the data generated using the simulation approach of Wang et al. may not reflect 
the real sequencing data structure, especially the nonlinear relationship. Therefore, the 
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frequency-based simulation approach was proposed in this thesis, aiming to mimic the real 
sequencing data structure and increase computational efficiency. To make our method 
expandable to specific sequencing reads, we made some effort to re-define the sequencing per-
based error rate that enables the expansion of the error rate estimation to specific sequencing 
reads instead of a fixed value for all the sequences in the sample. The adjusted per-base error rate 
definition provides more information according to the sequencing read compared with the 
original per-base error rate definition in the shadow regression approach.  
 
In Chapter 3, we expanded the error rate estimation to more diverse definitions of shadow. The 
shadow error rate investigated in Chapter 2 focused on error rates with substitution, which are 
the error rates studied in the majority of the literature that discusses sequencing errors. 
Specifically, the shadows studied in Chapter 2 are sequences with up to two base differences 
from error-free sequences, which were recommended in a previous study (4). In Chapter 3, we 
varied the definition of shadows to be sequences that are different from error-free sequencing 
reads by only one base, only two bases, and up to two bases, respectively. We also extended the 
estimation to deletion and insertion error rates, where the difference is  only one base, only two 
bases, and up to two bases from those of the error-free sequences.  In addition, we confirmed 
with the comments from a previous study (4) that using shadows that differ from the error-free 
sequences by up to two bases are good enough without excessive additional computational cost.   
 
In Chapter 4, we studied the association of the human microbiome with complex diseases and 
reviewed multiple approaches for processing and analyzing human microbiome data. We 
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provided detailed programming scripts about processing raw microbiome data into downstream 
analysis OTU format, calculating various alpha and beta diversities to estimate within-sample 
and between-sample distances, and analyzing the statistical association between the distance 
metrics of the microbiome and outcomes of interest.  We performed real data analysis using data 
from the foregut microbiome in esophageal adenocarcinoma to illustrate the statistical 
approaches.  
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5.2 Future Directions 
 
The human microbiome interacts with the environment dynamically and lives on surfaces with 
which we interact daily (42). The composition of the microbiome in the human body varies over 
time according to a person’s health, diet, lifestyle, social interactions, early antibiotic therapy, 
genotype, and environmental chemicals (45, 48). A cross-sectional study, in which only a single 
response is available, ignores the unstable and changeable characteristic of the human 
microbiome and does not sufficiently reflect the overall performance of the composition of the 
human microbiome over time.  In contrast to cross-sectional data, longitudinal data comprise 
repeated observation measures over time (227).  
Heuristically, a longitudinal study enables each microbiome sample to act as its own control, 
which allows for a reduction of the ever-present heterogeneity (227). Longitudinal analysis of 
time-series data helps to capture the outcome changes and progression of the microbiome  over 
time (79). Traditional longitudinal analysis, such as a simple regression of a dependent variable 
on a time measure, a general linear model with a fixed effect, or analyzing a single summary 
subject-level number that indexes changes for each subject, has limitations in detecting important 
signals and effects, and loses information on bacterial connections as the individual taxon is 
treated as a separate outcome, even in well-designed and conducted studies (79, 80). The 
analytical model for longitudinal data should take into account the correlation on repeated 
observations in order to obtain valid statistical inference on coefficient estimates. Ignoring 
bacterial correlations may lead to inefficient parameter estimates and inconsistent estimates of 
precision. (227) 
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A Bayesian network is a graphical model of joint multivariate probability that describes the 
statistical dependence and conditional independence between variables according to the data 
(228). It has the ability to capture complicated stochastic processes and has been shown to be a 
clear methodology for learning from noisy observations (228). In addition, a Bayesian network 
has the capability of describing interaction relationships between random variables. The 
established networks, working as a framework of relationships, can describe the dependence 
structure between multiple interacting quantities (228). Another widely-known advantage of a 
Bayesian network is the capacity to indicate causal influence. A Bayesian network has strictly 
mathematically defined probabilities and conditional independence statements, which implies the 
direct causal influence based on the network (228). Even though several assumptions may not be 
necessary in gene expression or taxa count data, the connections for some causality may be 
indicative based using the network to learn from the observational data (228). 
The Bayesian network consists of two components that describe the joint probability distribution 
of random variables. The first component is a directed or undirected acyclic graph for which the 
vertices represent random variables. The second component includes the probabilities that 
describe the conditional distribution of each variable given its parents in the graph. Under the 
Markov assumption, each variable is independent of its descendants given the corresponding 
parents in the graph (228). There are two commonly used approaches to describe the conditional 
distributions, depending on the data types of the variables. If the variables are discrete, the 
general representation involves constructing a table with the probability of each joint assignment 
to the corresponding parents specified. Specifying the conditional distribution of discrete 
variables is flexible and can describe any discrete conditional distribution in all possible 
densities, at the cost of an exponential increase in the number of free parameters. (228) If the 
145 
 
variables are continuous, the conditional independence relationship usually will be described 
with a linear Gaussian conditional density, where the variable is normally distributed with a 
mean linearly associated with the values of its parents, and the variance is independent of its 
parents. A joint multivariate Gaussian distribution will be attained under the assumption that all 
variables have linear Gaussian distribution in the network (228). In addition, the general 
approach to learn a Bayesian network is to use a scoring function that estimates the possible 
networks based on the training data and then to select the one with the optimal score (228).  
Multivariate Gaussian graphical models (GGMs) are widely used and considered as the standard 
approach to model the conditional independence relationship in multivariate Gaussian data (229). 
Multivariate GGMs have been successfully implemented in various areas, including health 
sciences, genomics, and economics. However, traditional multivariate GGMs may have 
limitations due to the lack of efficiency and accuracy, and loss of statistical power in handling 
high-dimensional data (229). Ni et al. developed the novel matrix-variate directed acyclic graph 
approach and extended it to model both directed and undirected graphs and paired it with an 
efficient Markov chain Monte Carlo (MCMC) algorithm (229). This matrix-variate graph can be 
a mixture of directed and undirected graphs (hybrid mGGM), i.e., when the prior ordering 
information is known, it may be represented as a directed graph; whereas when the prior ordering 
information is missing, it may be represented as a undirected graph. The hybrid mGGM 
approach enables accounting for the uncertainty of the graphical structure and providing 
regularized and sparse estimators under a Bayesian framework. The uncertainty consideration is 
essential when handling high-dimensional complicated datasets, as there may be several graphs 
that equally explain the observed data and which are well under the limited number of samples. 
(229) Based on previous simulation studies, the hybrid mGGM approach performs better than the 
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traditional alternative naïve directed acyclic graph approach, as well as the state-of-the-art 
Bayesian approach (230) and the matrix-variate Gaussian non-Bayesian graphical model 
approach in terms of the true positive rate, false discovery rate, and Mathews correlation 
coefficient (229, 231).  
In future studies, we will expand the cross-sectional analysis of the microbiome to an analysis of 
longitudinal microbiome data to study the specific relationships and general trend in microbiome 
taxa with time series information. The hybrid mGGM approach can be used to study the 
longitudinal microbiome data. If the prior ordering information is not clear, an undirected graph 
can be used to specify the microbiome taxa, while a directed graph can be used to specify the 
time. This approach will overcome the limitations in previous longitudinal studies of the 
microbiome, which ignored the interaction association between taxa,  and will be able to predict 
future changes in the composition of the microbiome over time. A Bayesian network has been 
successfully utilized to study time-series data in other areas, including clinical research and 
ecological prediction. So far, there is little in the literature that proposes using a Bayesian 
network to analyze longitudinal microbiomic data. The byproducts of using a Bayesian network  
are the estimated relationships of how one taxon influences another taxon over time (232).  
Before fitting the hybrid mGGM approach to a longitudinal dataset of the microbiome, there is a 
need to preprocess the high-dimensional raw microbiome data into an appropriate format. There 
are mainly two challenges involving the microbiome data before constructing a Bayesian 
network. The first challenge involves high percentage of zero counts in the OTU table. One 
essential problem in microbiomic data analysis is that there are many zeros in taxa counts, which 
will not allow for the direct use of standard statistical models. One approach to solve this issue is 
to combine the OTUs into the genera level that is a higher taxonomic level in the microbiome, 
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and then remove the genera with zero taxa counts in more than 90% of the sample. After the 
zero-checking stage, the remaining zero counts may be replaced by a pseudo value to better 
facilitate the estimation (usually 0.05 or 0.5). This replacement will not affect the estimation, 
which was confirmed by a previous study, especially when the replaced number is very small 
and the number of read counts is large enough (>>0.05 or o.5). These read counts will be 
converted into compositions, and a log-ratio transformation will then be applied to these 
compositional data (213, 214, 233, 234). Then the hybrid mGGM approach can be applied to the 
log-transformed compositional data to study the specific relationship structure and general trends 
in the microbiome genera over time. 
 
A simulation analysis may be applied to further study the performance of the hybrid mGGM 
approach on longitudinal microbiome data. One possible approach was introduced by using Chen 
and Li’s approach (235). This simulation approach uses a Dirichlet multinomial distribution to 
model the OTU counts, which takes the overdispersion of the OTU table into account. The 
maximum likelihood method is used to estimate the mean proportions and overdispersion 
parameters in the Dirichlet distribution of the OTU table. The taxa counts will then be generated 
using a multinomial distribution. The outcome of interest will be generated using a normal 
distribution if it is continuous; otherwise, if the outcome is binary, it will be generated using a 
Bernoulli distribution with the mean following a pre-specified distribution. (235) 
One of the major goals when using the hybrid mGGM approach to construct the Bayesian 
network is to integrate the taxa count data in the microbiome and capture the common structure 
of the genera-level taxa over time to find how the microbiome genera interacted with each other, 
which may be associated with the outcome. Another goal is to utilize the Bayesian network in a 
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clinical study, which may help to make predictions for future therapeutic strategies or disease 
prevention. For example, if the outcome of interest is a fatal or disease event with some 
microbiome genera available in high proportions, it would be feasible to inhibit both these 
genera and the associated genera in order to cure or prevent the disease. Previous simulation 
studies showed that the hybrid mGGM approach demonstrated superior performance compared 
to that of the conventional Bayesian network approaches in terms of increased computational 
efficiency, estimation accuracy, and statistical power (229). A Bayesian network also accounts 
for microbiome taxa interaction and is capable of predicting future changes in the microbiome’s 
composition over time.  
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